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ABSTRACT
 
Allison R. Gilbert, M.P.H.: Women with Co-occurring Disorders and Histories of Abuse: 
Moderators of Treatment Effect on Services Use and Costs 
(Under the direction of Marisa E. Domino, Ph.D.) 
 
 
Objective:  Women with co-occurring mental health and substance abuse disorders and 
histories of abuse are heterogeneous in symptom severity and use of support services, 
which may affect their treatment response.  This dissertation estimated differential effects of 
an integrated counseling intervention (IC) across sub-groups of women in this population on 
their outcome services use and costs.  
Data Sources/Study Setting:  Data from a national study conducted from 1998–2003.  
2,729 eligible women were recruited into IC or usual care study groups at nine study sites.   
Study Design:  Interviews were conducted with participants at baseline, three, six, nine and 
12 months regarding their service use.   
Data Collection/Extraction Methods:  Cluster analyses identified sub-groups of 
participants according to symptom profiles at baseline and separately according to service 
use profiles at baseline.  Regression analyses estimated the effect of IC, by sub-group, on 
participants’ outcome use of outpatient counseling, residential substance abuse treatment, 
medical and overall costs.  Latent class analyses were also conducted as a comparative 
approach to modeling sub-group effects of IC.  
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Principal Findings:  Among women with moderate-to-severe PTSD at baseline, the IC 
group had fewer counseling visits and a lower probability of having any medical costs at 
follow-up than the usual care group.  Among women who used counseling intensively at 
baseline, the IC group had fewer days of residential treatment at 12 months than the usual 
care group. Among women with high drug addiction and PTSD at baseline and women with 
high alcohol severity, those in IC had lower medical costs than women in usual care.  Latent 
class models produced generally consistent effects for residential treatment and medical 
costs.   
Conclusions:  IC was relatively inefficient for women whose predominant symptom at 
baseline was moderate-to-severe PTSD.  Efforts should be made to improve treatment and 
outcomes for these women.  IC worked well for women who at baseline used counseling 
intensively, had high drug addiction and PTSD, or had high alcohol severity.  Practitioners 
can identify these women among their patients and direct them toward IC if they are not 
already engaged.  Optimizing the effect of IC for women in this population can improve 
patient outcomes and conserve public resources.  
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CHAPTER 1
INTRODUCTION 
 
Co-occurring mental health and substance abuse disorders are devastatingly 
common among adults in the United States. (SAMHSA, 2002).  Among women with these 
disorders, it is particularly common to also have a history of abuse, which often results in 
post-traumatic stress (PTSD) (Goodman et al., 1997; Mueser et al., 1998; SAMHSA, 2002).  
Usual care is often ineffective in treating co-occurring disorders, as services are commonly 
fragmented, uncoordinated, and not comprehensive (SAMHSA, 2002).  Furthermore, current 
service delivery systems often do not adequately address special needs of women with co-
occurring disorders who also have histories of abuse (Commonwealth Fund, 1996; Harris 
and Fallot, 2001; Mueser et al., 2003).     
Integrated counseling (IC) is an innovative intervention for treating women with this 
complex constellation of problems, in which services are comprehensive, integrated, 
trauma-informed and include input from women who are consumers of mental health 
services, survivors of trauma, and recovering from addiction (Huntington et al., 2005).  
Evidence suggests that, on average, IC improves clinical outcomes better than usual care 
without significantly higher costs (Morrissey et al., 2005a; Morrissey et al., 2005b; Domino et 
al., 2005a; Domino et al., 2005b).   
Variations in symptom severity and in the way women utilize services, however, may 
influence the way IC effects their outcome service use and costs.  This dissertation sought 
to identify heterogeneous effects of IC across unique sub-groups of women who suffer from 
this debilitating triad of problems, to better understand for whom IC works best and how.  
Specifically, the aims of this dissertation were to (1) generate two sets of sub-groups – once 
each by symptom severity and services use and costs – that reflect diversity among women 
in this population, and (2) estimate differential effects of the IC intervention on outcome 
services use and costs across sub-groups. 
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CHAPTER 2
BACKGROUND 
 
Epidemiology of co-occurring disorders and abuse 
Seven to 10 million people in the United States suffer from at least one mental health 
disorder along with a substance abuse disorder (Kessler, 1994; Kessler et al., 1994; Kessler 
et al., 1996; Reiger et al., 1990).  Women make up a particularly high-risk subset of people 
suffering from co-occurring disorders.  They exhibit unique characteristics and certain life 
stressors – such as dependent children, homelessness, poor job skills, and weak social 
networks – that are often not shared by men and that require special attention in treatment 
outreach and planning (Zweben, 1996).  Women with co-occurring disorders are also much 
more likely than men to have histories of and be vulnerable to traumatic life events, such as 
physical or sexual abuse (Kessler et al., 1995; Gearon et al., 2003; Goodman et al., 1997, 
Lipschitz et al., 1996, Perkonigg et al., 2000; Hanson et al., 2002; Watkins et al., 2001). 
 Reports of lifetime interpersonal violence – often physical and/or sexual abuse – are 
particularly common among women with substance abuse disorders and women with mental 
health disorders, often doubling the reported prevalence among more generally 
representative populations of women (Najavits et al., 1997).  Reports of physical and sexual 
abuse range from 40 percent to nearly 100 percent in surveys of women with serious mental 
illness and surveys of women in treatment for substance abuse (Alexander, 1996; Fullilove 
et al., 1993).  Women suffering from co-occurring disorders are even more likely to have 
histories of abuse victimization and patterns of revictimization than women experiencing a 
single disorder, and are at particularly high risk for ongoing or future abuse as well 
(Alexander, 1996; Gearon et al., 2003; Goodman et al., 2001, Mueser et al., 1998).   
 Women who have histories of abuse victimization and co-occurring disorders have 
unique circumstances that dictate how appropriate treatment services are for their special 
needs and their willingness to use those services (SAMHSA, 2002).  For example, women 
may not respond well to confrontational approaches that are common in substance abuse 
treatment, and may avoid treatment altogether because they are fearful of losing custody of 
dependent children as a consequence (SAMHSA, 2002).  
 
Treatment services utilization: empirical evidence of patterns and predictors 
 Existing evidence regarding service use patterns and predictors for people suffering 
from co-occurring disorders is helpful in understanding how women with co-occurring 
disorders and histories of abuse use services.  There is strong evidence that usual care is 
often fragmented, uncoordinated, and not comprehensive, which is associated with gaps in 
services and suboptimal improvements in outcomes (SAMHSA 2002).  Parallel versus 
integrated treatment for co-occurring disorders is also associated with an increased risk of 
dropping out of treatment, non-adherence to interventions, and confusion among service 
recipients due to potentially conflicting messages about treatment and recovery being put 
forth, respectively, by the separate mental health and substance abuse services systems 
(Drake et al., 2004).   
 Evidence suggests that people with co-occurring disorders very commonly do not 
receive the specialty services that they need (Harris et al., 2005; Watkins et al., 2001).  An 
analysis of national household data from the Healthcare for Communities estimated that 72 
percent of individuals suffering from co-occurring disorders did not receive any specialty 
mental health or substance abuse services in the last year, and only eight percent received 
both types of care, either parallel or integrated (Watkins et al., 2001).   
 4
 People with co-occurring disorders do not use mental health services and substance 
abuse services uniformly either.  On average, individuals with these disorders are more 
likely to use mental health services as compared to substance abuse services (Harris et al., 
2005).  Predictors of receiving any mental health care include being female, having 
insurance (public or private), having bipolar or psychotic disorder (versus depression or 
anxiety), having been in prison or on probation in the last 12 months, and the strongest 
predictor, perceiving the need for mental health treatment (Watkins et al., 2001). 
 Less than one-third of people who have co-occurring disorders and who use mental 
health services receive any kind of substance abuse treatment (Harris et al., 2005).  
However, while people in this population are generally less likely to use specialty services 
for their substance abuse disorders than for their mental health disorders, there are certain 
characteristics that are associated with an increased likelihood of using substance abuse 
treatment.  An analysis of 2001 and 2002 data from the National Surveys on Drug Use and 
Health by Harris and colleagues suggested that the presence of severe mental health 
symptoms increases the likelihood that individuals with co-occurring disorders will receive 
substance abuse care along with mental health care services (2005).  Wu and colleagues 
(2003) found similar results in their analyses of 1997 data from the National Household 
Survey on Drug Abuse (the former name of the National Surveys on Drug Use and Health).  
Use of substance abuse treatment services increased from approximately three percent 
among individuals with only substance abuse disorders to 11 percent among those with co-
occurring mental health problems.  That proportion rose to 18 percent using substance 
abuse treatment services among people reporting two or more mental health syndromes 
that co-occurred with their substance abuse problems.   
 Other predictors of using substance abuse services among people with co-occurring 
disorders have been identified.  One study found that having been in prison or on probation 
in the last 12 months and having a perceived need for substance abuse treatment increases 
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the likelihood of using substance abuse services (Watkins et al., 2001).  Wu and colleagues 
also identified several predictors of substance abuse service use in their analyses, including 
being male, American Indian or Alaska native ethnicity, having past-year drug use problems, 
and having past-year mental health services use (2003).  The investigators also determined 
that college graduates and people who are employed full-time are less likely to use 
substance abuse services (Wu et al., 2003).   
 While evidence is strong that people with co-occurring disorders underutilize 
appropriate treatment services for their disorders, there is also evidence that they are high 
utilizers of other types of services, particularly medical services.  It is quite common for 
people to present to primary care practitioners with medically unexplained symptoms 
(Kroenke and Mangelsdorff, 1984).  There is evidence that clinical anxiety and depression is 
very common among people seeking help from primary care practitioners for unexplained 
medical symptoms (Smith et al., 2005).  Furthermore, patients with mental distress that seek 
help in primary care settings are also more likely to report many types of physical symptoms 
than people presenting without mental distress (de Waal et al., 2005).  These patterns of 
primary care utilization are a strong indication that primary care is, to some extent, used as a 
substitute for appropriate, targeted services.        
  Existing evidence demonstrates that people with co-occurring disorders also use 
high levels of crisis medical care, specifically inpatient hospital stays and emergency 
department (ED) visits.  Community-based studies commonly use hospital and ED visits 
among this population as proxies for lack of engagement in treatment, and more generally, 
negative outcomes (Drake et al., 2004).  Dickey and Azeni (1996) compared service use 
among Medicaid beneficiaries in Michigan for three sub-populations – patients with co-
occurring disorders who received substance abuse treatment, patients with co-occurring 
substance abuse disorders who did not receive substance abuse treatment, and patients 
with mental illness only.  Patients with a co-morbid substance abuse diagnosis were four 
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times more likely than patients with mental illness only to receive acute inpatient treatment 
at a hospital.  Furthermore, after discharge from the hospital those same patients were less 
likely to be accepted into residential substance abuse treatment programs (Dickey and 
Azeni, 1996).  Costs associated with treatment for patients with co-occurring disorders were 
significantly higher than for patients with mental illness only, particularly for inpatient 
hospitalizations, but also for general medical service costs as well (Dickey and Azeni, 1996).   
 More recent evidence also demonstrates elevated use of medical services among 
people with co-occurring disorders.  Clark and colleagues (2007) analyzed Medicaid claims 
from five states and compared use of inpatient hospital, ED, and community- based 
treatment services for beneficiaries with co-occurring disorders to beneficiaries with only 
mental illness or a substance abuse disorder.  Their results suggested that people with co-
occurring disorders had significantly higher odds of inpatient hospital stays and ED visits 
than people with a single disorder (Clark et al., 2007).  Furthermore, people with co-
occurring disorders were estimated to be significantly less likely to use community-based 
treatment services than people with mental illness only (Clark et al., 2007). 
 Women with co-occurring disorders and histories of abuse also tend to be high-
intensity service users (Kessler et al., 1997; Becker et al., 2005).   A group of 2,729 women 
with co-occurring disorders and histories of abuse from around the U.S. reported high rates 
of hospital stays (20.5 percent), emergency room visits (35.9 percent), medical clinics (60 
percent), and nights in jail (20.7 percent) during the three months prior to initiating integrated 
treatment (Becker et al., 2005).   
 
Treatment services utilization: estimates of heterogeneous effects 
 A limited amount of work has been done in an attempt to estimate differences in 
services utilization according to symptom severity among people with co-occurring 
disorders.  McGovern and colleagues (2007) used Medicaid claims from six states to 
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categorize people with co-occurring disorders into an existing, four-group symmetrical 
construct of symptom severity, evaluate the reliability of those categorizations, and estimate 
differences in service use across them.  They found that categorizations were relatively 
stable across states for the most severe and the least severe symptom categories, and also 
that people with severe psychiatric problems were significantly more likely to have used 
inpatient hospital or ED services than people with less severe mental illness (McGovern et 
al., 2007). 
 McGovern and colleagues’ study provides important information about how use of 
hospital services among people with co-occurring disorders varies generally by symptom 
severity (2007).  However, limitations of the study indicate important areas for further 
investigation.  The analyses did not control for patient characteristics that are likely to 
confound the relationship between symptom severity and use of hospital services, such as 
demographic characteristics, perceived need for care, and physical illness co-morbidities.  
More importantly, a symmetric four-category framework for symptom severity is likely too 
simplified and not reflective of how symptoms for these complex disorders may actually 
manifest, a point the investigators themselves make in describing the need for further 
research (McGovern et al., 2007).   
 
Integrated treatment: a new approach  
 Where treatment for individuals with co-occurring disorders has traditionally been 
fragmented – each disorder being treated in isolation by its respective treatment agency and 
paradigm – integrated counseling coordinates multiple-level health care needs by 
addressing mental health and substance abuse issues concurrently.  For women who also 
have histories of abuse victimization, integrated treatment must go one step further by 
incorporating trauma-informed counseling into service delivery to address possible PTSD 
and accommodate unique sensitivities of abuse victims.  It is not uncommon for women to 
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avoid seeking out or fully engaging in treatment because of shame or emotional distress 
from having been abused (Goodman et al., 1997).   
 A growing body of evidence suggests that an integrated approach to treatment may 
be associated with better outcomes among women with co-occurring mental health and 
substance abuse disorders who also have histories of abuse victimization and consequent 
PTSD as compared to traditional, uncoordinated services (SAMHSA, 2002; Najavits et al., 
1998; NASMHPD & NASADAD, 1998).  Women in this population who receive care from 
providers who are trained in working with trauma survivors and who take incremental steps 
in treating their co-occurring disorders and trauma symptoms may respond more positively 
and, in turn, have more marked improvements in their outcomes (Harris, 1994).     
  
WCDVS Six- and 12-month follow-up: clinical outcomes 
 This new approach to treatment – integrated, coordinated, and trauma-informed 
counseling and other services – was studied in the Women, Co-occurring Disorder and 
Violence Study (WCDVS) from 1998 – 2003.  An in-depth description of the study and its 
participants is detailed in Chapter 4.  Recent evaluations of WCDVS (Cocozza et al., 2005; 
Morrissey et al., 2005a; Morrissey et al., 2005b), demonstrated promising results for six- and 
12-month clinical outcomes associated with IC.  Aggregated results based on prospective 
meta-analysis of program-level effects at six-month follow-up indicated that intervention sites 
showed more improvement in mental health and substance abuse outcomes than 
comparison sites.   
Hierarchical linear models of program- and individual-level effects on outcomes were 
also estimated at six- and 12-month follow-ups (Morrissey et al., 2005a; Morrissey et al., 
2005b).  At six months, participants at intervention sites showed greater improvement in 
mental health, substance abuse, and post-traumatic stress symptoms as compared to 
participants at comparison sites, even when controlling for the effect of most individual-level 
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characteristics.  Four individual-level characteristics – high baseline alcohol- and drug-use 
severities, having been stalked or threatened, and having experienced physical abuse as an 
adult – were associated with improved outcomes in selected domains.  At twelve months, 
average improvements in mental health and PTSD outcomes among women at intervention 
sites seen at 6 months continued to increase, and the substance abuse outcomes leveled 
off, maintaining 6-month improvements (Morrissey et al., 2005b).  
 
WCDVS Six- and 12-month follow-up: service use and costs outcomes  
 Two analyses estimated health services use and total associated costs among 
WCDVS participants at both six- and 12-month follow-ups (Domino et al., 2005a; Domino et 
al., 2005b).  The analyses included health services that were delivered at study sites as well 
as at points of access external to the study.  Examples of services included are hospital 
days, ED visits, detoxification, and peer support groups, homeless or domestic violence 
shelter stays, and jail.  The Medical Expenditure Panel Survey (MEPS), Medicaid 
reimbursement rates, and existing literature were used as sources for costs of included 
services.  
 Domino and colleagues’ analysis of service use and costs at the six-month follow-up 
(2005a) was conducted from two policy-relevant payer perspectives – a governmental 
perspective, which encompassed a broad scope of medical and social services, and a 
Medicaid perspective, which included only medical services that would be covered by 
Medicaid.  The results indicated that, from either perspective, there was no statistically 
significant difference in total average costs between the group of participants receiving IC 
and the group receiving usual care.      
 The analysis of services costs at 12 months employed a societal perspective, which 
added an additional layer of direct and opportunity costs to the individual (e.g., 
transportation costs, time that could be spent earning wages) to the aggregation of total 
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costs.  Consistent with the findings at 6-months follow-up, the results at 12 months indicated 
that there were no statistically significant differences in total average costs between the IC 
and usual care study groups.  Combined with the improvement in clinical outcomes 
described above, these results suggested that treatment services for women who suffer 
from co-occurring disorders and who have been victims of abuse could be provided in a 
more cost-effective way with IC. This is particularly important when considering that these 
services are often funded by constrained public resources.           
 Two additional analyses by Domino and colleagues measured the changes in 
service use associated with the WCDVS intervention at six- and 12-month follow-ups 
(Domino et al., 2006; Chung et al., 2009).  Both analyses utilized two-part, difference-in-
difference regression models to estimate, first, the probability of having used a service at all, 
and second, the aggregate level of service use at six-months, given the service was ever 
accessed.   Results from the analysis of six-month follow-up data suggest that, on average, 
participants in the intervention arm used more outpatient group counseling than participants 
in the usual care study arm.  Conversely, no statistically significant differences in levels of 
service use were found between intervention and usual care study arms for psychotropic 
medication, peer support, individual counseling, or services external to the study such as jail 
time, homeless or domestic shelter stays, among participants who had accessed these 
services at some point before the 6-month follow up (Domino et al., 2006).   
 Preliminary results from the 12-month services use analysis suggested that 
participants in the intervention arm were more likely than those in the usual care arm to 
have used psychotropic medication, though no statistically significant difference in level of 
use was evident (Chung et al., 2009).  Residential treatment was the one study service in 
which participants in the intervention arm had, on average, a statistically significant higher 
level of use than usual care participants. 
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WCDVS 12-month follow-up: sub-group effects for clinical outcomes 
 While evidence for the average effects of IC was encouraging, it was not clear if IC 
was associated different outcomes for different sub-groups of women.  While no evidence 
exists in the literature regarding sub-group effects of IC on service use and costs, limited 
work has been done examining the effects of IC on clinical outcomes among sub-groups of 
women. The only existing sub-group analysis of WCDVS outcomes in the literature is a 
study conducted by Cusack and colleagues (2008).  The investigators evaluated the 
WCDVS data to determine whether the trauma-informed integrated counseling intervention 
affected clinical outcomes differentially across sub-groups of women according to baseline 
PTSD and substance abuse severity.   
 The investigators used k-means cluster analysis to generate clusters of women 
according to their symptom severity, and then predicted frequency of lifetime traumatic 
events, age at onset of mental health problems and poor physical health, and response to 
the WCDVS intervention.  Women in clusters with severe co-morbidity and severe PTSD, 
respectively, had the greatest number of traumatic events throughout their lifetimes.  Onset 
of mental health disorders was earliest among women whose predominant symptom was 
severe PTSD and among women who suffered from severe PTSD and severe drug and 
alcohol problems.  Poor physical health ratings were worst for those clusters of women as 
well.  Furthermore, Cusack and colleagues (2008) estimated that women with the most 
severe PTSD and substance abuse symptoms, and who were in IC versus usual care, had 
the greatest improvements in their post-traumatic stress symptoms. 
 
Contribution of the present study  
 Existing evidence suggests that, on average, IC is associated with better 
improvements in clinical outcomes than usual care with no significant difference in total 
costs.  Large, unmeasured variations in symptom severity profiles and in service use profiles 
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at baseline were not captured in analyses of the average effect of IC and may have masked 
the true effects of the integrated counseling intervention on heterogenous sub-populations.  
New evidence has demonstrated that there are indeed significant sub-group effects of IC on 
clinical outcomes (Cusack et al., 2008).  This dissertation aimed to fill a gap in the literature 
by adding important evidence about heterogenous effects of IC on services use and costs, 
an area of study that has recently been recommended by experts in treatment for co-
occurring disorders (Sacks et al., 2008).  Uncovering heterogeneous effects of IC on service 
utilization among women with co-occurring disorders and histories of abuse will help clarify 
further for whom in this population the intervention is most effective and how.     
 This study also builds on existing efforts to identify sub-populations of people with 
co-occurring disorders that are representative of how ranges of symptom severity commonly 
manifest in an attempt to understand variations in how they use services.  Specifically, this 
study improves on the existing quadrant framework for categorizing symptom severity by 
accounting for multi-dimensional combinations of symptoms that likely manifest in non-
symmetrical ways.  The groupings presented here will therefore have greater clinical 
significance in that they are more representative of how symptoms actually manifest in 
women in this population.  From there, more accurate assessments of treatment 
effectiveness can be made for people in the different sub-populations.   
 Furthermore, this study examined sub-group effects according to two distinct 
domains of participant characteristics as they enter treatment – symptom severity and 
service use patterns.  Each domain provides important information about women with 
different characteristics and makes it possible to estimate for whom the intervention is most 
effective.  Identifying women by their symptoms using clinical screening and assessment 
tools is part of routine practice for providers of mental health and/or substance abuse 
services and likely a practical approach.  Identifying women by their reported service use 
behavior, on the other hand, can be especially useful for general practitioners and other 
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providers who may not have direct access to women’s symptom profiles or the resources to 
conduct in-depth symptom evaluations themselves.  These practitioners can instead identify 
for whom IC is most appropriate by asking a few targeted questions about service utilization.  
By understanding if and how this intervention works differently for certain groups of women 
in this population, that knowledge can then be used by providers to improve how they target 
IC to their patients and by policy makers to improve the design and delivery of care for 
women who do not respond as well to IC.     
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CHAPTER 3
CONCEPTUAL FRAMEWORK 
 
Stratification to examine heterogeneous effects 
 The rationale for this study was to understand how variations in baseline symptoms 
or baseline service use and costs modify the effect of IC on later service use and costs.  The 
methodological rationale for this proposed conceptualization – versus previous studies that 
looked at average effects – was based in the epidemiologic concept of effect-measure 
modification.  Heterogeneity of effect, or effect-measure modification, refers to the 
differences in the magnitude of exposure effect (in this case, IC versus usual care) across 
levels of another variable (in this case, baseline symptom severity and baseline service use 
and costs) (Rothman and Greenland, 1998).  Stratification is a common method used to test 
for heterogeneity of effect and was used in this study to isolate sub-group effects of IC. 
 
Classifying symptom severity: an existing framework 
 In 1998, the National Association of State Mental Health Program Directors and the 
National Association of State Alcohol and Drug Abuse Directors presented a framework for 
assessing severity of co-occurring mental health and substance abuse disorders.  The 
model was based on symptom multiplicity and severity instead of specific diagnoses and 
divided symptom severity into four quadrants.    
For three important reasons, the quadrant model developed in 1998 is not optimal for 
use in categorizing women in the WCVDS according to baseline symptoms.  Firstly, the 
framework does not account for post-traumatic stress symptoms that may be associated 
with women’s experiences of interpersonal violence such as physical or sexual abuse, and 
thereby does not account for multiple dimensions of symptoms.  Secondly, the four-category 
framework does not make a distinction between major types of addiction, thereby lumping 
alcohol and drug addiction together and losing information that can be important for 
evaluating treatment effectiveness.  Thirdly, the framework proposed four categories with 
arbitrary cut points to reflect the following combinations of severity of mental health and 
substance abuse symptoms, respectively – low/low, low/high, high/low, and high/high.  This 
construct assumes that symptoms manifest in people in ways that reflect discrete, 
symmetrical categorizations.  The quadrant model has been criticized by experts for over-
simplifying the potential combinations and interactions of symptoms among people with co-
occurring disorders (McGovern et al., 2007; Keyser et al., 2008).  So, it is even more likely to 
be unrepresentative of how the triad of PTSD and co-occurring disorders plays out 
empirically.        
 
Cluster analysis: an alternative method of classification 
Cluster analysis is an alternative approach to categorizing data according to multiple 
dimensions.  A statistical algorithm constructs a parsimonious set of sub-groups, or clusters, 
that are data-driven and that reflect natural groupings of observations.  This is particularly 
useful for creating meaningful categories of women with co-occurring disorders and abuse 
victimization, among whom there are likely many combinations of complex symptoms and 
varying degrees of severity.  If symptoms among women in this study population had, in 
fact, played out as conceived in the 1998 framework, those patterns would emerge in cluster 
analysis and would provide supporting evidence for the quadrant model.  If, on the other 
hand, symptoms actually manifested in a less symmetrical way, those unique patterns would 
emerge in cluster analysis, as well. 
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Theoretical bases for predictors of treatment services utilization 
 People suffering from co-occurring disorders comprise a seriously underserved 
population faced with multiple and complex barriers to effective care (SAMHSA, 2002).  
Barriers to appropriate care range from shortcomings in the coordination of care in separate 
substance abuse and mental health systems, to poor access to services, to disabling 
symptoms and poor social supports that may inhibit seeking out care.  These factors can 
confound the effect of a treatment intervention on patient outcomes.  Two different models 
of health care services utilization are helpful in framing the context and predictors of service 
use for treatment of co-occurring disorders.   
The Behavioral Model of Health Services Use identifies three primary dimensions 
that determine an individual’s use of health services:  predisposition to use services, 
enabling or disabling factors, and need for care (Andersen, 1995).  Predisposing factors by 
definition precede episodes of illness for which services may be sought, and may include 
demographic characteristics such as age, race, gender, and education.  Enabling factors are 
resources that facilitate receiving health care services, such as health insurance, income, 
and availability in the user’s community.  The third dimension encompasses both need for 
care as perceived by the individual and need as evaluated by providers. 
Another model lends insight into the pathway to care for mental health services and 
uncovers the underlying selection process.  Goldberg and Huxley (1980) illustrated the 
progressive steps toward accessing psychiatric care and the barriers to advancing for each 
level.  The model identifies predictors of psychiatric care at three basic states: (1) who seeks 
care; (2) among those who seek care, whose mental health disorders are detected; and (3) 
among those whose disorders are detected, who are channeled to psychiatric care and who, 
instead, are channeled to primary care services.  Initially seeking care is associated in this 
model with symptom severity, psycho-social stress, attitudes of relatives, availability of 
medical services, and ability to pay.  Disorder detection is predicted by provider 
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characteristics, such as interview techniques and training, as well by patient traits such as 
presenting symptoms and socioeconomic characteristics.  Referral to psychiatric care 
(versus primary care) for treatment is influenced by patient symptom severity, attitudes of 
patient and family, and availability and quality of psychiatric services.   
 
Clustering variables: categorizing participants according to two variable constructs 
 Participant sub-groups were constructed in two different ways – once according to 
baseline symptom severity, and again according to baseline service use and costs – with 
the expectation that each construct would group participants differently and have a unique 
association with the intervention that would drive unique responses to IC.  Integrated 
counseling was designed and intended to treat women’s disorders and trauma symptoms, 
so it may be that differences in the effect of the intervention depended on baseline symptom 
severity.  One the other hand, services utilization theory suggests that factors other than 
symptoms (e.g., predisposing characteristics, enabling resources) drive people to seek, 
access, and engage services use differently.  Services utilization behaviors before IC, 
therefore, may have been what most strongly influenced the engagement in IC and its 
consequent effect on outcome services use and costs.   
 The two clustering constructs are also very different in how they can be used in 
practice settings to identify unique sub-groups of women within this population to indicate for 
whom IC is likely to be relatively effective or ineffective.  The advantage of identifying 
women by symptom sub-group is that some providers (e.g., psychiatrists, psychologists) are 
assessing diagnoses as part of their regular course of treatment and can easily distinguish 
in which sub-groups their patients belong.  The disadvantage of identification by symptom 
sub-group is that it may not be practically feasible for practitioners that lack the diagnostic 
skills and resources necessary to conduct symptom assessment.   
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The relative ease of sub-group identification is an advantage of the service use and 
cost sub-grouping.  All practitioners, regardless of formal training, can quite easily identify 
women according to the service use and cost patterns by asking relatively simple questions 
about their level of use of different types of services, such as outpatient counseling, 
residential treatment, and medical services.  Answers to these questions will indicate to 
which service use and cost sub-group a given person likely belongs, and with that 
information the provider can then anticipate who effective IC is likely to be.           
Theory and empirical evidence informed the identification and organization of sub-
group modifying effects on the intervention as well as the selection of covariates to control 
for confounding effects so that the direct effect of IC could be measured (Figure 1).   
Based on theory and existing evidence regarding service use patterns and treatment 
responses among people with co-occurring disorders, and particularly, women with co-
occurring disorders and histories of abuse, I generated and tested three study hypotheses: 
(h1) Differences in the effect of IC on service use and costs will be found 
among women in different sub-groups. 
The Behavioral Model of Health Services Use (Andersen, 1995) and the Pathways to 
Care in the Community model for mental health services use (Goldberg and Huxley, 1980) 
both suggest that utilization of services varies based on many characteristics, including 
symptom severity, perceived need for care, availability, and socio-economic status.  Existing 
empirical evidence supports the theory that different populations of people with co-occurring 
disorders use certain services differently depending on the severity of their psychiatric and 
substance abuse symptoms (McGovern et al., 2007; Cusack et al., 2008; Keyser et al., 
2008).  Based on the service utilization theories, I expect to find empirical differences in the 
effect of IC on service use and costs according to baseline symptom severity and according 
to baseline service use patterns among women with co-occurring disorders and histories of 
abuse.    
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(h2) Intervention effects on service use and costs will be stronger in clusters 
of women who use high levels of services at baseline than in clusters of women who 
have high symptom severity scores at baseline. 
Based on empirical evidence that people with co-occurring disorders tend to over-
utilize medical services, the IC intervention is expected to have a stronger effect of reducing 
potentially inappropriate use or over-use of services and associated costs (e.g., inpatient 
hospital stays, ED visits) among women who were high-intensity service users at baseline 
as compared to women who where characterized by high-severity symptoms at baseline.  
The effect of IC across clusters in the two constructs will be compared qualitatively by 
examining distributions and R-squared statistics that indicate the percent of variability in the 
outcome that is explained by the model. 
(h3) Intervention effects on service use and costs will be stronger in clusters 
representing high outpatient counseling use at baseline as compared to clusters 
representing low outpatient counseling use at baseline.    
It is expected that women who tended to be higher utilizers of counseling services at 
baseline will have had the strongest intervention effects on their outcome service use and 
costs.  Counseling was a fundamental element of the intervention, and so these women 
would likely have tended to use the intervention services more intensively than women who 
used counseling less intensively or less often before starting treatment.  High-intensity use 
of a primary intervention service is expected to be associated with the strongest intervention 
effects on outcome service use and costs. 
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CHAPTER 4
STUDY DESIGN AND DATA 
 
WCDVS study design 
 From 1998 through 2003, Women, Co-Occurring Disorders, and Violence Study 
(WCDVS) implemented a quasi-experimental treatment protocol to serve the complex needs 
of women with co-occurring disorders and histories of abuse victimization (McHugo et al., 
2005; Cocozza et al., 2005; Morrissey et al., 2005a, Morrissey et al., 2005b).  Nine 
intervention sites were selected to implement integrated intervention programs.  The sites 
were quite varied in the focus and modality of their service delivery – some provided 
primarily mental health services, other substance abuse services; some sites provided 
outpatient treatment, others residential treatment or a mix of both (McHugo et al., 2005). 
Participating sites were also given the freedom to choose which treatment model they would 
follow in developing and implementing the intervention services, so long as the models were 
group-based and trauma specific (McHugo et al., 2005). 
 Four core requirements were imposed on the nine sites regarding the content of the 
integrated-services intervention they provided study participants.  First, each site was 
required to provide comprehensive intervention services and had to incorporate eight 
specific service elements, including outreach and engagement, parenting skills training, 
resource coordination and advocacy, and crisis intervention.  Second, each site was 
required to implement a set of services that were integrated, both clinically and 
organizationally.  In other words, sites needed to be coordinated with other agencies and 
individual providers participating in their patients’ care.  Third, services provided by each site 
were required to be trauma-informed, meaning that potential circumstances and symptoms 
specific to having been a victim of abuse had be acknowledged and addressed in the 
intervention services.  Fourth, each site was required to incorporate CSR involvement into 
their intervention services.  Specifically, [C]onsumers of mental health services, [S]urvivors 
of trauma, and women in [R]ecovery (CSR) were to be included in the development, 
implementation, and evaluation of sites’ intervention services (McHugo et al., 2005). 
 Each of the nine study sites contributed an intervention site and a comparison site 
that provided usual care.  In most cases, comparison sites were similar in terms of service 
sector, but not necessarily geographic proximity (McHugo et al., 2005).  Intervention and 
comparison sites were both varied in terms of the types and scope of services provided, 
however, the comparison sites did not specifically implement the intervention services.  
Women were enrolled in a quasi-experimental or non-random manner into the intervention 
site and from a comparison agency(s) that provided usual care in the same or an adjacent 
community.  Target enrollment for each participating site was 150 – 200 participants.  
Mental health, substance abuse, and PTSD outcomes, as well as service use and costs 
were measured for study participants at baseline, six- and 12-months during in-person 
follow-up interviews.  Telephone interviews were also conducted at three- and nine-months 
to measure service use.   
 The quasi-experimental study design may have limited study validity to an extent.  
Non-randomized site matching introduced the potential for site-specific characteristics 
confounding the effect of the intervention.  Further, non-random participant recruiting could 
have produced study groups that were unbalanced, also allowing the introduction of 
systematic differences in participants across groups that could confound the effect of the 
intervention on outcomes.  In the case of WCDVS, the quasi-experimental study design was 
arguably preferable over a randomized design for several reasons.  First, within-agency 
randomization would have likely led to contamination of the intervention effect to the usual-
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care participants because of system-level training (e.g., staff training on IC) that occurred in 
a preliminary phase of the study.  Furthermore, evidence suggests that clinicians consider 
trauma-informed treatment to be superior to usual care, so it would likely have been difficult, 
if not infeasible, to justify randomizing patients to usual care groups (McHugo et al., 2005).  
Lastly, a group of women participating in the design of the integrated counseling intervention 
who were in recovery from these disorders asserted that participant randomization to study 
conditions would not be reflective of real-world circumstances. 
 
WCDVS study population characteristics 
 The study sample at baseline included 2,729 eligible women.  Overall, these women 
had a very complex and challenging set of mental and physical health problems, trauma 
histories, and present life circumstances (Becker et al., 2005).  At baseline, participants 
were, on average, high-intensity users of addiction treatment, and over half were living in 
residential substance abuse treatment facilities (Becker et al., 2005).  Nearly half of the 
women had at least one psychiatric hospital stay in the past, and among that proportion, the 
average number of admissions was 4.5.  Trauma experiences among participants were 
commonly severe, the majority reporting having been victims of physical abuse, sexual 
abuse, emotional abuse, neglect, and often, some combination those abuses.  Complicating 
their disorder and trauma symptoms, many women in this population reported having poor 
physical health status.  Nearly half reported having a serious health problem, and only 22 
percent considered their current health to be excellent or good (Larson et al., 2005).   
 Along with a constellation of health problems and being victims of abuse, many 
WCDVS participants faced other life circumstances that put them at a general disadvantage 
and likely made treatment and recovery more challenging.  The majority was under-
educated and under-employed – nearly half did not finish high school, and only 12 percent 
reported working either full- or part-time (Becker, 2005).  Twenty percent of participants 
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reported being in jail or a correctional facility during the three months prior to enrolling in 
WCDVS.  Many of the women were unstable parents, as well.  Of the 87 percent who had 
children, 40 percent had lost custody of all their children.  Women’s reports about how they 
viewed themselves as parents often reflected a lack of confidence, as well.   
 There were 2,006 women who completed interviews at both baseline and six-month 
follow up.  At 12-months’ follow-up, 2,026 women completed interviews.  The odds of 
dropping out before the 6- or the 12-month follow-ups were not statistically different for the 
intervention and comparison groups.  Older age and higher education levels were 
associated with statistically lower odds (p<.05) of dropping out before six months or 12 
months, while black women and participants with higher drug severity scores at baseline 
were more likely to drop out before both six months and 12 months.  Higher post-traumatic 
stress scores at baseline were associated with slightly greater odds (p<.05) of dropping out 
before completing a 12-month interview.  
 
Assessing receipt of intervention services 
 An important consideration about the study conditions is the extent to which 
participants received the services intended for the study arm to which they were assigned.  
It is possible that there was some crossover among participants, in which women in the 
intervention arm did not receive integrated counseling or women in the usual care arm 
received intervention services.  The potential for study-arm crossover is particularly relevant 
in WCDVS as participation did not preclude women from engaging in treatment beyond the 
study conditions, and participants were interviewed about all services used during follow-up 
intervals, not just services encompassed in the study. 
The interview data were examined carefully in an attempt to uncover the extent to 
which participants received study services as intended.  Interview questions covered a 
broad range of services use, from those specific to the intervention such as counseling, 
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case management, and peer support services received, to other services that may have 
been used during a given interval, such as hospital stays, nights spent at a shelter, or nights 
in jail.  The IC condition was to have a foundation of individual and/or group counseling and 
include services with the four key dimensions described above – comprehensiveness, 
integration, a trauma-informed approach, and CSR involvement.  The comparison condition 
was not a prescribed set of usual-care services, but instead reflected a range of typical 
services use by women meeting the study criteria.   
Another feature of WCDVS that further complicates the measurement of IC versus 
usual care services was how the study condition was defined.  While women in each study 
arm were recruited from study sites and comparison sites, the follow-up interviews did not 
explicitly ask them to limit their responses regarding services use to the study sites.  
Therefore, reporting could to some extent reflect services used in the larger community as 
well.  Nothing in the interview schedule could definitively indicate the presence of each of 
the four required components in intervention services; however, several questions did refer 
to important aspects of comprehensiveness and integration in services that participants 
received.   
Group counseling, either in residential or outpatient treatment settings, was to be the 
core service activity for delivering the intervention.  Almost 90 percent (89.71%) of 
intervention group women reported participating in group counseling sometime during the 1-
year follow up period.  Nearly 80 percent (78.23%) of these women reported receiving 
violence/abuse/trauma-specific treatment (VAT) during group counseling.  Inasmuch as the 
receipt of counseling that has a VAT component can be used to measure receipt of 
intervention services, this would suggest that 70 percent of intervention participants actually 
received these services.  Eighty percent of comparison group participants reported group 
counseling sometime over the 1-year follow up period, of whom more than half (54.54%) 
reported VAT was included.  If participant reports of receiving counseling with a VAT 
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component are used as a measure of intervention receipt, almost 44 percent of all 
comparison participants actually received intervention services.  Based on that indicator 
alone, the data would suggest that there was substantial study-arm cross-over amongst 
study participants.   
Another measure of intervention services participation is self-reported receipt of 
trauma-informed care for other service types beyond group counseling, such as individual 
counseling, case management, and peer support services.  These variables, as indicators of 
intervention receipt, captured more participants in each study arm than VAT in group 
counseling.  Among women who reported group counseling participation, but with no VAT, 
86.14 percent of the intervention group reported receiving VAT in at least one of the three 
additional intervention services.  Nearly 73 percent of comparison-group women also 
reported VAT in individual counseling, case management, and/or peer support services.  
Combining having used group counseling or other intervention services with a VAT 
component, 94.45 percent of intervention group women reported receiving some VAT during 
the one year of follow up, as compared to 83.35 percent of comparison group women.     
A final indicator that intervention services were to some extent integrated and 
delivered with a VAT component was identified in items rating participants’ perceptions 
about the care they had received.  Three items in particular addressed the extent to which 
service providers helped the patient understand the connection between abuse, mental 
health and substance abuse problems; if providers explained abuse-related symptoms in 
understandable way; and if providers were helping the patient recover from the traumas in 
her life.  Almost all participants in both intervention and comparison groups (97.83 percent 
and 96.67 percent, respectively) agreed or strongly agreed with at least one of these three 
statements about their providers’ approach.   
Questions about where participants received the intervention services were included 
in the interview and could potentially indicate treatment receipt, however response rates for 
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participants’ reporting of facility or program names were poor.  Only 50 percent of women 
receiving outpatient group counseling and approximately 40 percent of women receiving 
residential group counseling provided facility or program names at which that counseling 
took place.  Therefore we are unable to use attendance at intervention clinics as a reliable 
measure of treatment receipt. 
The data from participant interviews summarized above suggest that over 90 percent 
of women in the intervention arm received at least one required dimension of the 
intervention that featured VAT.  That many women in the comparison group also reported 
receiving intervention-type services – over 50 percent reported some service with VAT – 
may indicate that self-reports of services use in this study serve as an imperfect measure for 
intervention receipt.  This is consistent with findings from an analysis by Chung and 
colleagues (2007) about the reliability of self-reports of treatment content among women 
participating in WCDVS.  The investigators determined that reliability ranged from moderate 
to substantial levels of agreement in participants’ self-reports about any versus no use of 
services.  However, reliability of reported service content was low – particularly for trauma 
content in counseling services – with agreement ranging from none to moderate (Chung et 
al., 2007). 
It may be that low specificity (many false-positives) of interview questions and the 
relatively uncontrolled nature of self-reporting, itself, yielded more reports of intervention-like 
services than were actually received.  Also, counseling, case management, or peer support 
services outside the intervention arm (i.e., usual care) may well have addressed trauma, but 
that would not necessarily be indicative of “integrated counseling” as defined for the 
WCDVS intervention.  Conversely, provider sensitivity to the unique needs of study 
participants did not necessarily translate into direct observables – a trauma-informed 
approach could have been unrecognized by a participant and therefore not reflected in her 
reporting of services received.   
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The degree of formality with which trauma was addressed during treatment 
distinguished treatment as it was delivered in the intervention condition as compared to 
usual care, but may not have been detected.  Considering how pervasive trauma is among 
women with co-occurring disorders (Kessler et al., 1995; Gearon et al., 2003; Goodman et 
al., 1997, Lipschitz et al., 1996, Perkonigg et al., 2000; Hanson et al., 2002; Watkins et al., 
2001), casual mentions of trauma may have been very common in usual care treatment 
services.  Even brief mentions of trauma may have inclined study participants in the usual 
care group to report having received care with a VAT component.  Their having actually 
received services with a VAT component, as intended for the intervention, was unlikely 
given the evidence that usual care services generally do not adequately address trauma for 
women in this population (Goodman et al., 1997).  In intervention services, on the other 
hand, VAT issues were addressed formally as a part of treatment.  This important distinction 
between causal mention and formal address of trauma could not be teased out in service 
use questions in the study interview, and so may account, in part, for high levels of receiving 
VAT services among women in the comparison group.       
 Because nearly all women in the intervention group reported receiving some 
intervention-type services, this analysis was conducted based on the assumption that 
intervention-arm participants received integrated counseling and comparison-arm 
participants received usual care from their recruiting comparison site or elsewhere in the 
community.  A process evaluation of WCDVS provides supporting evidence for this 
assumption about comparison sites (Huntington and Moses, 2005).  Comparison sites that 
were selected for site visits were judged to have had generally low levels of integration 
(Huntington and Moses, 2005).  Site investigators determined that specific strategies to 
insure involvement and integration of CSRs (consumers/survivors/women in recovery) in the 
intervention services were nearly absent in comparison sites (Huntington and Moses, 2005).  
Finally, intervention sites were generally successful in incorporating the eight core services 
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identified for comprehensiveness by developing trauma-specific services.  Meanwhile, 
trauma-specific services were absent from most comparison sites (Huntington and Moses, 
2005).  While these evaluations of the study condition suggest that the intervention services 
were generally exclusive to the intervention sites, the impossibility of accurate measurement 
of intervention receipt is a limitation of these data.   
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CHAPTER 5
METHODS 
 
Clustering methodology 
 This dissertation sought to divide the WCDVS sample into more homogenous sub-
groups of women according to their baseline symptom severity and separately according to 
their baseline service use, and to conduct analyses separately for each unique sub-group. 
The organization of study participants into distinct sub-groups was carried out using two 
clustering methods, combining hierarchical and k-means clustering analyses.  While cluster 
analysis is a useful and unique tool for generating data-driven sub-groups, an inherent 
estimation limitation is that it requires the analyst to ultimately, and largely qualitatively, 
decide what is the correct number of clusters.  Unlike regression analyses, there is no test 
statistic to use in cluster analysis that clearly supports or refute the results.  Another 
limitation of cluster analysis is the lack of consensus about whether to standardize variables 
at all, and if so, by what method.  To assess the robustness of the cluster analysis results, 
we also used clusters created by latent class analysis. We then ran a series of regression 
models for each outcome of interest, generating IC effect estimates for each cluster.  In this 
section, the process of creating clusters and the analyses within clusters are described. 
 Cluster analysis is an approach to categorizing data according to multiple 
dimensions that constructs a parsimonious set of clusters that are driven by the data and 
thereby represent existing patterns within them.  Cluster analysis has been used in recent 
health psychology and health services research for grouping people according to sets of 
characteristics (Lee et al., 2008; Jin-An et al., 2008; Clatworthy et al., 2005; Henry, 2005; 
Halpern et al., 2004; Jason and Taylor, 2002; Sugar et al., 2004; Sugar and James, 2003; 
Lenert et al., 2000; Sugar et al., 1998).  By this method, categories (clusters) are no longer 
necessarily equally-weighted and instead are determined by relative positions of cluster 
centers, points that are derived using a statistical algorithm.  Data points are then assigned 
to clusters for which center values of each dimension of interest are closest to their own 
values.  While many approaches to cluster analysis are possible, these analyses were 
based on a two-step process recommended in contemporary texts (Khattree R and Naik D, 
1999) and current scientific literature (Clatworthy J, et al., 2005; Mandara J, 2003; Henry 
DB, et al., 2005, Milligan GW, 1980, Milligan GW, 1985, Milligan and Cooper, 1988), in 
which the number of clusters and their starting centroids are first obtained using a 
hierarchical method, and second, the clustering solution is then improved by optimizing 
assignment of observations to clusters using k-means clustering. .   
 
Standardization of variables 
 Input variables for both clustering constructs were first rescaled before being used 
for cluster analysis.  Because the clustering variables, particularly the service variables, 
were based on different raw scales, the variation in their ranges was large.  For example, 
the number of days spent in residential substance abuse treatment among participants in 
the three months before baseline ranged from zero to 114 days.  On the other hand, costs of 
psychotropic medications in the three months prior to baseline ranged from $0 to $2,325.  
Unequal scaling yields unequal variable weights, giving more relative influence to variables 
with large ranges during cluster assignment.  For these analyses, each variable was divided 
by its range, which placed the four variables on a single scale while leaving relative 
variability before and after transformation unchanged. 
 Each variable was then multiplied by 100 so that all input variables for symptom and 
service cluster analyses had potential ranges of 0 to 100.  This was recommended as the 
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optimal rescaling approach by Milligan and Cooper (1988) after conducting a simulation 
study to compare different approaches to standardization.  Their study demonstrated that 
standardization by division by the range consistently performed best in recovering the 
underlying structure of the cluster as compared to other approaches.  Several other 
rescaling approaches were explored, including generating various quantiles of baseline 
values.  The approach recommended by Milligan and Cooper was ultimately selected based 
on their supporting evidence (1988) and because the clusters formed using this rescaling 
approach produced the strongest difference in IC effects across clusters on outcome service 
use and costs. 
 
Hierarchical clustering procedure 
 The first step of the cluster analyses was to apply Ward’s method, a hierarchical 
agglomerative analysis, to identify the most appropriate number of clusters.  The 
agglomerative process begins by assigning each observation to its own cluster, and clusters 
are then successively combined to form larger sub-groups.  The Ward’s algorithm begins by 
assigning each observation as its own cluster and then continues to link individual clusters 
together to form larger clusters based on a dictated distance metric.  The recommended and 
predominating metric, squared Euclidean distance, was used here (Milligan, 1985).  This 
measure was calculated by summing the squared differences between observations for 
each input variable, generating the shortest (or as-the-crow-flies) distance between two 
points.   
 Dendrograms, or tree diagrams, were generated from the results of the Ward’s 
analyses, by which the most appropriate cluster solutions were selected.  A dendrogram 
represents the distance between clusters as they are combined, as well as the number of 
observations assigned to each cluster.  The greater the vertical distance is between a given 
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cluster and the remaining clusters, the more unique it is.  Visual inspection of the 
dendrograms was used to assess the number of unique clusters that exist in the data.    
 The dendrogram generated from Ward’s hierarchical analysis of the three symptom 
severity variables suggested, upon visual inspection, that the data grouped naturally into six 
or seven clusters.  Cohen’s kappa statistics for K-means clustering, as performed on two 
random sub-samples of the analytic sample, once for each possible cluster solution, 
suggested that the seven-cluster solution was more reliable than a six-cluster solution 
(eight-cluster solution: 0.66, p <.0001; seven-cluster solution: k = 0.70, p <.0001; six-cluster 
solution: k = 0.64, p <.0001).   
 The Ward’s cluster analysis grouped participants’ service use and cost profiles into 
four or five apparent clusters.  K-means cluster analysis results for the two randomly-split 
sub-samples were tested for agreement.  The Cohen’s kappa statistics for the four- and five-
cluster solutions (k = 0.44, p<.0001 and k = 0.90, p<.0001, respectively) indicated that the 
five-cluster solution produced more stable results.   
 
K-means clustering procedure 
 The second step for the cluster analysis was to use the mean values, or centroids, 
from the Ward’s cluster solution as starting seeds for k-means cluster analysis.  K-means 
analysis is an iterative partitioning approach, which unlike hierarchical methods, allows 
cases to be reclassified into other clusters throughout the assignment process to optimize 
cluster fit.  The k-means clustering algorithm iteratively assigns observations to clusters to 
minimize the within-cluster distances and maximize the distance between cluster centroids.     
 The final step taken in the cluster analysis was to validate the selected cluster 
solution, also according to an approach commonly recommended in current literature 
(Mandara, 2003; Henry, 2005, Clatworthy, 2005).  Because there is no single, definitive 
approach for selecting the optimal number of clusters, validating the results adds important 
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support to the goodness of fit for the selected cluster solution.  The stability of cluster 
solutions was assessed by (a) randomly dividing the study sample in two, (b) performing 
cluster analysis on sub-sample 1, (c) performing cluster analysis on sub-sample 2, and (d) 
performing cluster analysis on sub-sample 2 again, the second time using the final centroids 
generated from the analysis of sub-sample 1 as starting points.  The stability of results 
between the two analyses of sub-sample 2 was assessed using Cohen’s kappa statistic, a 
common measure of rater agreement, and standards of reliability proposed by Shrout 
(1998).  
 After cluster solutions were finalized for each baseline construct, clusters were 
assessed for similarity according to their mean values for input variables.  As a sensitivity 
analysis, clusters with similar profiles were combined to test the stability of IC effects for 
distinct sub-groups of women in the study population.  Baseline symptom clusters C2-Sx 
and C3-Sx had similar mean values for alcohol and addiction severity.  Both clusters had 
high PTSD symptom scores relative to the other symptom clusters, though the mean PTSD 
score in C3-Sx was nearly 70 percent higher than in C2-Sx.  To assess the stability of the 
results of the final seven-cluster solution, these two clusters were combined to use for a 
sensitivity analysis of the sub-group effects of IC.        
 For all outcomes, the regression analyses in which symptom clusters C2-Sx and C3-
Sx were combined produced null results for the effect of IC.  As there were significant effects 
of IC for C2-Sx on counseling use and external medical costs using the final 7-cluster 
solution, the null results for the combined cluster indicate that collapsing those observations 
into one sub-group diluted the unique effects that are evident specifically for women whose 
predominant symptom is moderate-to-severe PTSD.  Therefore, the final 7-cluster solution 
for baseline symptom sub-groups was retained for use in generating IC effect estimates.        
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 The end result was that each woman was assigned to a cluster, and dummy 
variables for those cluster assignments were used as control variables in the regression 
models and interacted with the IC indicator variable to form the key explanatory variable.        
  
Measures 
 Participants’ use of services was assessed at baseline, and at three- , six-, nine-, 
and 12-month follow ups.  An intention-to-treat analytic approach was implemented, thereby 
including all women in the final study sample and results, regardless of whether they 
followed through with treatment, as long as they completed baseline and 12-month 
interviews.  Services such as hospital stays, jail stays, nights in shelters, residential 
treatment stays were reported as number of days.   
 
Dependent variables 
 Service use outcomes were operationalized as four separate dependent variables, 
comprising use of outpatient group and individual counseling services, residential treatment 
use, costs of medical services used that were external to the WCDVS intervention, and total 
costs of all services reported (Table 1).  These outcomes were selected because they 
reflect a broad scope of services — two basic types of treatment for substance abuse and 
mental health disorders, as well as use and cost of services that may, in part, be used as 
substitutes for appropriate care.   
 In particular, outpatient counseling was a fundamental component of IC and 
considered to be a key service associated with improving outcomes among women in this 
population.  Therefore, assessing the extent to which the IC intervention affected counseling 
use across sub-groups of women in the study was an important indicator of the dose of the 
intervention that was received.  Residential substance abuse treatment was also an 
important outcome to measure because it is one of the most clinically- and resource-
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intensive treatment services for co-occurring disorders.  While it is a critically important 
mode of treatment for people with severe addiction disorders (Greenfield et al., 2004; Shou 
et al., 2006), it is possible that its use might be reduced in an appropriate way if IC services 
are used successfully.    
 External medical costs – defined here as costs associated with inpatient hospital 
stays, ED visits, and outpatient medical services – were selected as a study outcome based 
on the existing evidence that people with co-occurring disorders, including women who also 
have histories of abuse, tend to be high utilizers of medical services, including primary care 
and, particularly, crisis services such as inpatient hospital stays and ED visits.  By modeling 
the effects of IC on external medical costs, we were able to estimate the extent to which 
different sub-populations of women in the study may have used IC as an appropriate 
substitute for medical services as treatment for their co-occurring disorders.   
 The effect of IC on total overall costs was also selected as an important outcome, as 
it provided information about whether and to what extent total overall costs changed among 
sub-groups of study participants after initiating IC versus receiving usual care.  Overall costs 
were measured by aggregating study participants’ use and costs of all services addressed in 
the study interviews.  These costs were associated with the following twelve services:  
inpatient hospital stays, ED visits, detoxification services, residential substance abuse 
treatment, homeless shelter stays, nights in jail, outpatient counseling (group), outpatient 
counseling (individual), case management, outpatient medical services, psychotropic 
prescription medication use, and peer support services. 
      Health services costs were aggregated according to a societal perspective, as 
recommended in guidelines for cost-effectiveness analysis (Gold et al., 1996), accounting 
for both direct and indirect costs to study participants and their families as well as the costs 
associated with their care.  Services costs were specified directly following Domino and 
colleagues (2005a, 2005b), in which services were assigned a unit cost for each type.  Cost 
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sources for outpatient medical visits, hospital days, and ED visits included MEPS, Medicaid 
reimbursement rates, and the existing scientific literature where government data were not 
available (AHRQ, 2005; Weinstein et al., 1997; Welsh and Quirke, 1997; Coalition for 
Homelessness, 2001; Domino et al., 2004; Nevada Provider Rates Task Force, 2002; 
Humphreys and Moos, 1996; US Bureau of Labor Statistics, 2001; US Bureau of 
Transportation Statistics, 2001; US General Services Administration, 2005; Gold et al., 
1996; Ettner et al., 1997; Simon et al., 2001).   
 Indirect costs to the patients associated with their use of external medical services 
(i.e., transportation costs, lost wages due to time receiving treatment) were specified after 
estimates used by Domino and colleagues (2005b).  Transportation costs were calculated 
assuming a 40-minute round trip at $.35 per mile (U.S. Department of Transportation, 2001; 
U.S. General Services Administration, 2001).  Hourly wages were based on averages 
statistics from the U.S. Labor Department for women and were reduced by a factor of nearly 
30 percent to reflect lower earnings of people with mental illness (Bureau of the Census, 
2001; Ettner et al., 1997). 
 
Independent variables
 The primary independent variable of interest was treatment group assignment, 
modeled as a dummy indicator variable.  The differential effect of IC in contrast to the 
comparison arm was measured across each cluster domain using two respective vectors of 
cluster dummy variables, a treatment group dummy variable, and two vectors of interaction 
variables: (1) baseline symptom severity cluster dummy variables, each one interacted with 
the treatment variable and (2), baseline service use/cost clusters, interacted with the 
treatment variable.  The coefficients on the interaction variables represent the extent to 
which cluster position modifies the effect of integrated counseling as compared to usual care 
on follow-up service use and costs.  
 37
 Clustering variables: Baseline symptom severity 
 Several well-validated, widely used survey instruments were used in WCVDS to 
measure women’s disorder-related symptoms and were used as the basis for the baseline 
symptom severity clustering in analyses by Cusack and colleagues (2008) as well as in 
these analyses.  Mental health symptoms were measured using the Global Severity Index 
(GSI) from the Brief Symptom Inventory, a well-validated and widely used survey instrument 
for assessing mental health status, functioning, and symptoms (Derogatis, 1993).  The GSI 
comprises a 53-item scale, where each response ranges from 0 – 4 for increasing symptom 
severity in the past seven days.  A score of 1.35 was the mean item-level GSI score among 
the WCDVS study population at baseline (McHugo et al., 2005).   
 Post-traumatic stress symptoms in WCVDS participants were measured using the 
Posttraumatic Stress Diagnostic Scale, which assesses 17 key symptoms, ranging in score 
from 0 – 3 as severity increases, associated with the experience of PTSD.  Established cut-
points exist to categorize symptom severity, so that Mild = 1-10, Moderate = 11-20, 
Moderate-to-Severe = 21-35, and Severe = 36-51 (Foa, 1995; Foa et al., 1997). 
 Substance abuse behavior was measured using the Addiction Severity Index (ASI), 
another well-validated instrument for assessing non-diagnostic degree of addiction based on 
self-reported use and perceived problem seriousness in the past 30 days (McLellan, 1992).  
The ASI includes two composite scores –ranging from 0 – 1 as severity increases – one 
each for alcohol (ASI-A) and drugs (ASI-D).   
 The GSI variable was highly correlated with the PTSD variable (r = 0.7687, p < 
0.0001) and therefore was excluded from the cluster.  Participants’ post-traumatic stress 
scores were instead used to represent general mental health symptoms in the grouping of 
observations.  Sixty-six observations had missing values for PTSD scores.  GSI scores were 
regressed on PTSD scores using participants with non-missing observations for both 
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variables (R2 of 0.58, r = .0.76), and the predicted values were calculated and imputed for 
the 68 missing values.  Addiction severity scores for alcohol and drugs were missing for two 
and eight participants, respectively.  For each addiction score, the mean value for 
participants for each variable was imputed for missing values.  As a sensitivity analysis to 
determine the effect of imputing predicted values for mental health scores in place of 
missing PTSD scores, regression models were re-run dropping all participants for whom 
PTSD scores were missing at baseline.    
 The sensitivity analysis to determine the effect of missing baseline PTSD values on 
effect estimates generated similar results across all outcomes.  Upon dropping the 66 
observations missing baseline PTSD values, both effect estimates and their strength of 
statistical significance were slightly attenuated.  Only in the case of follow-up outpatient 
counseling did the conclusion change, as the effect of IC for women in the moderate-to-
severe PTSD group as compared to the low symptom group dropped below the Type 1 error 
threshold of 5 percent, the standard by which all study analyses were assessed for 
statistical significance (β = -0.39, p = .045 with imputed values for missing baseline PTSD; β 
= -.38, p = .054 after dropping missing PTSD observations).  The remaining three outcomes 
maintained statistical significance for the same sub-groups with slightly lower effect sizes 
and p-values.  This effect is likely due to the reduction in power from dropping 66 
observations from the models.  Due to the largely consistent results across these two 
analytic approaches, the sample with imputed values for PTSD was used for final analytic 
models.     
 
Clustering variables: Baseline service use  
 A second set of clusters was constructed to categorize WCDVS participants 
according to baseline service use patterns.  Four main service use and cost dimensions 
were included in cluster analysis: (1) psychotropic medication costs, (2) outpatient individual 
 39
and group counseling, (3) residential treatment use, and (4) external medical costs.  These 
four dimensions reflect a broad scope of services –psychiatric, psychotherapeutic, 
substance abuse rehabilitation, and medical care – that were used and reported by study 
participants.   
 
Control variables
 Drawing upon both Andersen’s model of health services utilization and Goldberg and 
Huxley’s model of the pathway to psychiatric care, as well as current literature regarding 
services use by people with co-occurring disorders (Andersen, 1995; Goldberg & Huxley, 
1980; Harris & Edlund, 2005; Watkins et al., 2001; Wu et al., 2003), a set of variables was 
identified as potential confounders of the relationship between IC and outcome service use 
and costs and were thus controlled for in the analyses.  Age, race, and education were 
controlled for as predisposing factors.  Having a serious physical illness or disability was 
also included as a predisposing factor for services use in these analyses, as participants 
were reporting medical service use as well as mental health or substance abuse treatment 
services they used during the study period.  Answering affirmatively to any of the following 
was considered a disabling factor for use of treatment services: current physical or 
emotional abuse (within past six months), participant feeling unsafe with someone she 
knows well, or participant feeling afraid of someone with whom she lives or who lives 
nearby.  Having health insurance (public or private) and court-ordered participation in 
treatment were included as enabling factors.  Finally, a perceived unmet need for care by 
participants was included as a control variable.  The unmet need variable was 
operationalized so that women who responded that services they felt they needed but hadn’t 
received in the past three months – ranging from mental health, substance abuse, or trauma 
services, to case management services or medical services – were considered in these 
analyses as having perceived unmet need for care.  
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 The following observations were dropped from all study analyses due to missing 
data: one due to missing information about race, three due to missing information about 
education level, three due to missing information about whether treatment was court-
ordered, and nineteen due to missing information about perceived need for care, yielding a 
sample of 2,001 individuals.   
 
Regression analyses 
Modeling selection bias and attrition 
 Given that treatment assignment was not randomized, logistic regression analysis 
was used to test for selection bias among the study population, in which case certain 
participant characteristics would make them more or less likely to be in a given treatment 
group.  In addition, to test for attrition bias, logistic regression analyses were conducted to 
determine whether treatment group assignment or other participant characteristics predicted 
drop out by six months and drop out by 12 months.  In the final analytic sample, black 
women were statistically significantly more likely to be in the intervention group than White 
women (OR = 1.653, p<.001).  Women who were court-ordered to received treatment for at 
least one of their disorders were also more likely to be in the intervention group than women 
who were not court-ordered to receive treatment (OR = 1.49, p<.001).  There was not a 
statistically significant difference in loss to follow-up by 12 months for women in the 
intervention group versus the comparison group (OR = 1.20, p=.077).  There were, however, 
increased odd of dropping out by 12 months associated with other participant 
characteristics.  Being relatively young, less educated, or African-American was associated 
with increased odds of dropping out, as was relatively severe PTSD and drug addiction 
scores.  Because these characteristics were associated with increased drop-out, these 
study results may not be as representative of women with these characteristics as compared 
to the rest of the women without in the sample.  This limitation withstanding, this analytic 
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sample was used for all analyses because there was not a significant difference in drop-out 
across study arms, reflecting a good balance in the sample for the primary effect of interest.    
. 
 
Regression models 
 Regression models were estimated to assess the effects of baseline symptom 
severity and baseline service use/cost patterns, respectively, on each of the four outcome 
domains – outpatient counseling use, residential treatment use, external medical costs, and 
total costs.  A vector of interaction terms for each cluster with the intervention variable was 
used to estimate the intervention effect across clusters, along with a group of relevant 
control variables.   
 The effects of IC across clusters on 12 month outpatient counseling visits and 
residential treatment days were estimated using zero-inflated negative binomial models 
because of the count nature of these variables.  A two-part model was estimated for external 
medical costs due to a large proportion of zeros (5.4 percent).  A logit model was estimated 
to predict the probability of having any medical costs, and an Ordinary Least Squares (OLS) 
regression was modeled to estimate the level of costs for participants who had any.  An OLS 
model was used to estimate the effect of IC versus usual care across clusters on total 
overall costs.    
 A series of specification tests were run for all models.  For counseling visits and days 
in residential treatment – the two count-variable outcomes – the variable distributions were 
assessed according to the dispersion alpha parameter for over-dispersion and the Voung 
test for zero-inflation to determine whether Poisson, negative binomial or zero-inflated 
negative binomial models were appropriate.  The Wald test was conducted to test 
hypotheses regarding the value of explanatory-variable constructs.  The Ramsey RESET 
test (Ramsey, 1969) was used to test for non-linear parameter combinations to optimize 
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functional form in the models with count and continuous variables as outcomes.  For both 
external medical costs and overall costs at 12 months, the Wooldridge test was used to 
determine whether or not the dependent variables should be log transformed, the Ramsey 
RESET test was used to check functional form for each model, and the White test was 
selected to test for heteroskedasticity, or unequal variances, in their respective error terms.   
 Goodness-of-fit tests (counseling: χ2  =  278010.6, p<0.00001; residential treatment: 
χ2 =140561.7, p<0.00001) and large variances indicated that Poisson models were not 
appropriate for modeling the two count-type outcomes variables, number of counseling visits 
and days in residential treatment.  The Voung test of zero-inflated versus standard negative 
binomial model confirmed that, due to a large proportion of zeros for counseling visits and 
residential treatment days (13.29 percent and 48.58 percent, respectively), the zero-inflated 
negative binomial model was most appropriate for both variables (counseling: z = 10.25, 
p<0.00001; residential treatment: z = 13.36, p<0.00001).    
 For outpatient counseling and residential treatment, the results of the Wald test 
indicated that the coefficients for all study site dummy variables were not equal to zero 
(counseling: χ2 = 6.87, p<.05; residential treatment: χ2 = 326.73, p<.001), indicating that the 
site variables contributed unique information and should therefore be modeled as separate 
variables.  The same conclusions were made for Wald test results for study site construct for 
the cost outcomes.  For the residential treatment model, results of the Wald test indicated 
that the hypothesis that all race variables were equal to zero could not be rejected.  Based 
on those results and to save degrees of freedom in the model, the race indicators were 
excluded.  Regression results for residential treatment were similar when the race variables 
were retained and when they were excluded, so the decision to exclude race variables here 
did not change the effect estimates.  The Ramsey RESET test results suggested that 
neither model would be improved by adding non-linear parameter combinations.   
 43
 For the two cost outcomes – external medical costs and total overall costs – results 
from the Wooldridge test for dependent variable log transformation (Wooldridge, 2003) 
indicated that log transformations were not necessary in either case upon comparing the 
pseudo-R-squared statistic for the logged models and the R-squared for the unlogged 
models, respectively.  Ramsey RESET results for both outcome variables did not indicate 
that inclusion of non-linear parameterizations of independent variables would improve 
functional form.  Results from the White test rejected the null hypothesis that error variances 
were homoskedastic in the error terms for both external medical costs and total overall costs 
(p<.001 for both), and error terms were corrected for heteroskedasticity.       
 Differential effects of IC versus usual care were calculated for clusters with 
significant treatment effects for a representative woman of mean age, 36.67 years old, who 
had not completed high school, reported having a serious physical illness or disability, was 
currently at risk for abuse, had some type of medical insurance, no perceived unmet need 
for care, and was recruited at a study site that provided mental health and substance abuse 
services in a residential treatment setting.   
 
Latent class analyses 
 A second approach to estimating sub-group effects of IC on follow-up service use 
and costs was explored as an accompaniment to cluster analysis.  Latent class analysis 
(LCA) is a statistical method that, like cluster analysis, classifies similar observations into 
sub-groups (McCutcheon, 1987).  Where cluster analysis groups observations according to 
their measures for a set of observed input variables, latent class analysis estimates two or 
more treatment effects where the characteristic that splits the sample is latent.  Potential 
advantages of latent class analysis include probabilistic modeling of class membership, a 
diagnostic statistic for determining the number of clusters, accommodation of non-normal or 
mixed distributions for input variables, and no need for variable standardization.    
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 Model parameters are generated using maximum likelihood estimation – first, the 
proportion of cases that fall into n latent classes was estimated, and second, the probability 
of each observed characteristic was estimated for cases within each latent class.  I 
conceived of a two-class latent class structure that reflects a group of women with an 
unobserved unmet need for IC and a group of women with no unmet need for IC.  This 
expected latent structure was informed by theory and empirical evidence.  The Andersen 
model of health care utilization and Goldberg and Huxley’s model of pathways to mental 
health care in the community identify a set of complex conditions and characteristics that 
influence the likelihood of someone seeking out, accessing, and receiving care.  Those 
factors range from health system characteristics that enable the access of needed care to 
socio-economic characteristics that influence a person’s efforts and attitudes regarding 
using services.  Complex combinations of these influences on service utilization result in an 
individual’s need for care being met or not.   
 Existing empirical evidence has demonstrated that people with co-occurring 
disorders often have a significant unmet need for care (SAMHSA, 2002; Watkins et al., 
2001; Harris et al., 2005; Wu et al., 2003).  Therefore, the presence or absence of unmet 
need among WCDVS participants, an arguably unobserved collection and interaction of 
conditions and characteristics that influence how they use services, is conceived as the two-
class underlying construct for the latent class analysis.  This construct is similar to those 
used in existing studies of health services utilization among sub-groups of health services 
users (Deb and Trivedi, 2002; Deb and Holmes, 2000; Deb and Trivedi, 1997). 
The effect of IC was then estimated three ways for each latent class of unobserved need for 
care among study participants – once generating classes according to baseline symptoms, 
a second time according to baseline service use patterns, and third time according to both 
baseline symptoms and service use.   
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 The three separate baseline constructs each provided unique information in 
generating the classes of participants according to unmet need for care and so were all 
explored for LCA models.  Modeling the underlying structure of unmet need for IC by 
baseline symptom severity revealed the extent to which symptom severity predicted unmet 
need for IC and, in turn, how women’s unmet need associated with their symptoms 
moderated the way IC affected their follow-up service use and costs.  Applying the service 
use/cost construct to the assignment of participants to two latent classes based on unmet 
need for care, on the other hand, demonstrated both the probability of the presence or 
absence of unmet need in this study population according to their service use patterns, and 
how IC effects the way they use services at follow-up depending on whether they have 
unmet need for care.  Using both symptom and service use characteristics at baseline to 
model the presence or absence of unmet need allowed for both a broader association with 
unmet need and any interaction between symptoms and service use that may have 
influenced the likelihood of having unmet need for care.   
 For each baseline construct, I used the same subset of input variables from cluster 
analysis to model the probabilistic assignment of participants to the two latent classes –  
‘unmet need’ and ‘no unmet need’.  For the symptom-based latent classes, probabilities of 
participants being in one of the two latent classes were generated using the alcohol, drug, 
PTSD, and treatment group assignment variables.  For the service-based model, 
probabilities of latent class membership were estimated according to baseline counseling, 
psychotropic medication costs, residential treatment days, external medical costs, and the 
treatment group variable.  A third construct was modeled, combining the symptom and 
service use variables and treatment group variable to generate probabilities of class 
membership. 
 The effect of IC on each outcome was then modeled by class and included the 
covariates described earlier to control confounding bias.  For the counseling and residential 
 46
treatment outcomes, a negative binomial density was specified to account for the large 
proportion of zeros in the dependent variables.  For external medical costs and total overall 
costs, the models were estimated assuming that the distributions of the error terms from 
these outcome variables were normal, as a specification test for log transformation of the 
dependent variable (Wooldridge, 2003) indicated that the fit of the non-transformed 
variables were better than the log transformed versions. 
 Three-class models were also estimated to explore the possibility that an 
underlying unmet need for IC services might more accurately be modeled as having  three 
levels – low, medium and high levels of unmet need for targeted services.  One benefit of 
latent class analysis is the availability of a diagnostic test statistic to assess goodness of fit 
in the attempt to identify the correct number of latent classes.  The Bayesian Information 
Criterion (BIC) assesses goodness of fit by identifying the model with the most appropriate 
number of latent classes.  The BIC weighs the predictive power of the number of parameters 
in the model against the increase in consequent variance that is introduced along with the 
parameters.  The value of the BIC statistic increases along with unexplained variance in the 
dependent variable and the number of predictor variables included in the model.  When 
comparing goodness of fit across two models a lower BIC value indicates better fit. 
 Ultimately, only two-class models would converge for each of the four outcomes.  It 
was possible to estimate models with more than two classes, but only when all covariates 
were excluded.  Models without covariates yielded biased results, as important confounders 
of the effect of IC were not accounted for.  Furthermore, no comparison of results could 
have been made between LCA models without covariates and cluster analysis regression 
models with covariates.  Therefore, I was unable to compare the two-class model to models 
with three or more latent classes of unmet need for IC (e.g., low, medium, high unmet need) 
to assess which model structure provided the best fit for the data.    
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Statistical programming 
 All statistical programming for these study analyses were conducted using Stata® 10 
(StataCorp LP, College Station TX) and SAS® 9.1 (SAS Institute, Inc., Cary NC).   
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CHAPTER 6
RESULTS 
  
 Of the 2,026 women who completed 12-month interviews, 2,001 were included in the 
final analytic sample.  Table 2 includes demographic and other relevant information for the 
analytic sample and according to study group.  Baseline values for the symptom severity 
and service use clustering domains are presented in Tables 3 and 4. 
 
Cluster analysis results 
 Cluster analysis: symptom severity profiles 
  The WCDVS participants were characterized according to seven distinct symptom 
severity profiles (Table 5).  Each cluster was described based on relative symptoms with 
other clusters and assigned a label for the sake of brevity.  Approximately 17 percent of 
participants had relatively low symptoms on substance abuse and mental health dimensions 
at baseline (C1-Sx).  About 21 percent experienced moderate-severe PTSD, but low alcohol 
and drug addiction symptoms (C2-Sx).  Nearly 18 percent of participating women had 
moderate-severe PTSD and relatively high drug addiction symptoms (C3-Sx), while 11 
percent of women reported moderate-to-severe PTSD and severe drug addiction symptoms 
(C4-Sx).  About 8.5 percent of women had high severity symptoms across all three 
dimensions, particularly alcohol and drugs (C5-Sx), and another 10 percent of women had 
relatively high alcohol severity accompanied by moderate drug and PTSD (C6-Sx).  A final 
group of women (C7-Sx) were characterized by extremely high alcohol severity, high drug 
severity, and moderate-to-severe PTSD.  Across all symptom severity clusters, drug 
addiction severity scores were relatively low as compared to alcohol addiction and PTSD 
scores and displayed less variation.    
  
Cluster analysis: service use profiles 
 Five distinct service use/cost patterns emerged among participants at baseline 
(Table 6).  Thirty-nine percent of participants had low usage for group or individual 
outpatient counseling and days in residential treatment, as well as low costs associated with 
psychotropic medication use and external medical services in the three months prior to 
baseline (C1-Serv).  Sixteen percent of participants were low users of counseling services, 
but fairly high users of residential treatment (C2-Serv).  Approximately 12 percent reported 
using high levels of counseling and low use of residential treatment, with average costs for 
psychotropic medication and external medical services (C3-Serv).  Another 13 percent of 
women in the study were characterized as being very high users of residential treatment, 
with above average costs for medication and external medical services (C4-Serv).  Finally, 
almost 20 percent of participants had high costs for psychotropic medication and external 
medical services, along with average use of counseling and low use of residential treatment 
(C5-Serv).   
 The distribution of study participants in the final analytic sample across baseline 
symptom and service clusters demonstrates that the two clustering constructs did, indeed, 
comprise unique groups of women (Table 7).  Relatively large proportions of women who 
were in the service cluster characterized by low-intensity service use (C1-Serv) were also in 
the low-severity symptom cluster (C1-Sx) (22.14 percent), the sub-group of women marked 
by moderate-to-severe PTSD (C2-Sx) (22.65 percent), and the sub-group of women with 
moderate drug addiction and severe PTSD (17.37 percent).  Overall, however, the 
participants were well distributed across symptom and service clusters, resulting in unique 
sub-groups of study participants across the two clustering constructs. 
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Regression analysis results 
 There were significant effects of IC as compared to usual care on service outcomes 
for several symptom and service clusters (Tables 8 and 9).   
Outpatient counseling 
 By the 12 month follow-up, there were no statistically significant differences in 
outpatient counseling visits among women in the IC group as compared to women in usual 
care group.  Further, when considering only the main effect of cluster membership, there 
were no significant differences in counseling use across women in the different symptom 
and service sub-groups. 
 Among women with low alcohol and drug addiction symptoms and moderate-to-
severe PTSD at baseline (C2-Sx), however, those in the IC group had statistically 
significantly fewer outpatient individual or group counseling visits than women in this cluster 
who received usual care (Table 10).  A representative woman in sub-group C2-Sx who was 
in the IC treatment group would have a predicted 27.38 fewer counseling visits during the 
year than her counterpart in the usual care group.  The predicted number of counseling 
visits over 12 months for a representative woman who characterized by moderate-to-severe 
PTSD at baseline was 77.83.  A woman in the same sub-group with equivalent 
characteristics but who was instead in the usual care group would have a predicted 105.21 
counseling visits by 12 months.   
 Certain model covariates had significant effects on counseling use, as well.  Women 
who were court-ordered to engage in treatment had significantly more counseling visits than 
women who were not.  On the other hand, being Black or other race, and either not finishing 
high school or having at least some college were associated with lower use of counseling at 
follow-up than being White or having a high school education. 
 
Residential treatment use 
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 There were no statistically significant differences in the number of residential 
treatment days used by 12 months between symptom clusters or between service clusters 
when not accounting for the effect of treatment group assignment.  For both the symptom 
and service cluster constructs, on the other hand, women in the IC treatment group across 
clusters had significantly more residential treatment days by 12 months than women in the 
usual care group (Table 11).      
 There were significant differences in residential treatment use across study groups 
among women who had low-severity symptoms at baseline (C1-Sx).  Women in this sub-
group who were in the IC group had significantly more residential treatment days at follow-
up as compared to their counterparts who were in the usual care group.  A representative 
woman in C1-Sx who was in IC had a predicted 125.37 days of residential treatment at 
follow-up as compared to 92.56 days if she were in the usual care group. 
  Unique effects of IC were also detected for three service use/cost sub-groups.  
Among women characterized as low-intensity service users at baseline, a representative 
woman C1-Serv who was in IC had a predicted 105.87 days of residential treatment at 
follow-up as compared to 82.53 days if she were in the usual care group.  Among women in 
the sub-group characterized by a high level of counseling use at baseline (C3-Serv), those 
in the intervention group used fewer days of residential treatment at follow-up as compared 
to women in the usual care group.  For a representative woman in the C3-Serv sub-group, 
being in the IC group was associated with having a predicted 9.2 fewer days in residential 
treatment than the counterfactual condition of this woman being in the usual care group.  
The predicted number of days spent in residential treatment for a representative woman in 
this cluster (C3-Serv) who was in the IC group was 83.45 as compared to 92.65 days for a 
woman with the same characteristics in the usual care group.     
 A similar significant effect of IC on follow-up residential treatment use was also found 
among women in the sub-group of high-intensity residential treatment users at baseline (C4-
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Serv).  A representative woman in sub-group C4-Serv who was also in the IC treatment 
group had a predicted 8.16 fewer days in residential treatment than her counterpart in the 
usual care group.  The average woman in this sub-group of high-intensity residential 
treatment users at baseline who was in the IC group had a predicted 108.01 days in 
residential treatment at 12 months as compared to 116.17 days if in the usual care group.  
Having some college education was associated with having spent fewer days in residential 
treatment at 12 months than having only completed high school. 
 
External medical costs 
 There were several unique effects for IC and symptom sub-groups on 12-month 
external medical costs (Table 12).  There was no significant difference across symptom 
clusters in the probability of having any medical costs when holding treatment group 
assignment constant.  Conversely, when holding sub-group effects constant, the odds of 
having any medical costs was over three times higher (OR = 3.32, p<.05) for women in the 
IC study group in all clusters as compared to women in the usual care group.  Women in the 
moderate-to-severe PTSD sub-group who were in IC had significantly lower odds (OR = 
.214, SE = 0.909) of having any medical costs compared to women in this sub-group who 
were in the usual care group. 
 The level of external medical costs was also predicted by symptom-cluster 
membership (Table 12), indicating substantial differences in costs predicted by baseline 
symptoms.  Integrated counseling appeared to lower medical costs for two symptom sub-
groups. Women with high drug addiction and PTSD at baseline (C4-Sx) and women with 
severe alcohol addiction at baseline (C6-Sx) who were in the IC group both had relatively 
low medical costs as compared to women in the same respective sub-groups who were 
instead in the usual care group.  Among women who had any medical costs at 12 months, 
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those in these two high-severity clusters (C4-Sx and C6-Sx) who were in the IC treatment 
group had significantly lower medical costs than their counterparts in the usual care group.   
 Accounting for both the probability of having any external medical costs and the level 
of costs, a representative woman in the low-severity symptom group (C1-Sx) had $1,554 
more in external medical costs at follow-up than if in the IC group as compared to the usual 
care group.  A representative woman characterized by moderate-to-severe PTSD and 
severe drug addiction at baseline (C4-Sx) had $5,863 less in external medical costs if in the 
IC group as compared to the usual care group.  A representative woman who was 
characterized by severe alcohol addiction at baseline had $5,938 less in external medical 
costs if in the IC group versus the usual care group.    
 In the symptom-cluster model, Black women were less likely to have any external 
medical costs at follow-up than White women.   Also, among women with any external 
medical costs, women with high drug addiction and PTSD severity at baseline (C4-Sx), as 
well as women with high alcohol addiction severity at baseline (C6-Sx) had significantly 
lower costs for external medical care than women in the low-symptom group.  Having a 
serious illness or disability and having insurance were both associated with having higher 
medical costs than not having an illness/disability or not having insurance.       
 There were no statistically significant differences in the effect of IC across service 
clusters on external medical costs (Table 13).  There were, however, overall differences in 
the level of medical costs across clusters.  Among women who had any medical costs, 
women who were characterized as high-intensity residential treatment users at baseline 
(C4-Serv), regardless of treatment group assignment, had significantly lower medical costs 
at 12 months than women in the low-intensity services use baseline sub-group (β = -
2,310.56, SE = 1,156.288), possibly indicating that residential treatment substituted for 
external medical care to a certain extent.  Women who were in the baseline sub-group 
marked by high psychotropic medication costs and high external medical costs (C5-Serv), 
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on the other hand, had significantly higher external medical costs at 12 months than women 
who were low-intensity service users at baseline.   
 Two covariates also had effects on the probability and level of external medical 
costs.  Women who reported having a serious illness or physical disability had almost four 
times the odds of having any external medical costs in the service-cluster model as 
compared to women without illness or disability, as well as a relatively high level of costs 
among those women who had any.  Women who reported being court-ordered to undergo 
treatment had about half the odds of having any medical costs as compared to women who 
were not court-ordered to treatment.   
 
Total overall costs 
 Several symptom and service clusters had significant effects on overall total costs at 
12 months, but only when controlling for the effect of treatment group assignment.  Women 
in sub-groups characterized by high-severity substance abuse and/or high PTSD – including 
the high drug and PTSD cluster (C4-Sx), the high alcohol addiction cluster (C6-Sx), and the 
high drug and alcohol addiction cluster (C7-Sx)  – had significantly higher overall costs than 
women in the low symptom group (Table 14).  Similarly, women in the four service clusters 
characterized by various elevated levels of service use and/or costs at baseline (C2-Serv, 
C3-Serv, C4-Serv, and C5-Serv) all had significantly higher overall costs compared to 
women in the low-intensity service use group when not accounting for the effect of treatment 
group assignment.   
 Only one symptom sub-group demonstrated a significant IC effect on total overall 
costs when also accounting for treatment group assignment.  Women in the high alcohol-
addiction-severity baseline cluster (C6-Sx) who were in the IC study group had lower overall 
costs at 12 months than women in this sub-group who were in the usual care group (β=-
12,882.55, SE = 6,060.984) (Table 14).  A representative woman with severe alcohol 
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addiction at baseline who was in the IC group had predicted overall costs of $49,861.  The 
same woman in the usual care group had predicted overall costs of $56,645.  Similar to 
external medical costs, having a serious illness or disability was associated with higher 
overall costs than not having an illness/disability in both the symptom cluster and service 
cluster models.  In addition, both models also indicated that women who reported being 
currently at risk for abuse or having been court-ordered to engage in treatment had 
significantly higher overall costs than women who were not at risk for abuse and women 
who were not court-ordered to treatment.    
   
Latent class analysis results  
 The two-class models for latent effects of IC on outcome service use and costs 
generated similar results across all three approaches to modeling the probability of latent 
class membership – one classifying the presence or absence of unmet need for care based 
on treatment group assignment and baseline symptom severity, a second based on 
treatment group assignment and baseline service use patterns, and a third based on 
treatment group assignment, symptoms and service use.  Given similar magnitude and 
statistical significance of effects across the three modeling approaches, only results from 
models using treatment group assignment, baseline symptoms, and baseline service use 
are presented in accompanying tables.  There were significant effects of IC versus usual 
care on two service outcomes (Table 15).     
 The two-class models for latent effects of IC on outpatient counseling indicated 
that there were no significantly different effects among participants with an unobserved 
unmet need for IC treatment as compared to women with no unmet need for IC (Table 16).  
There were significant effects on outcome counseling use for other participant 
characteristics.  Among women with no unmet need for IC, Black women had used 
significantly less outpatient counseling than women who were White.  Also among women 
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with no unmet need for IC, women who were court-ordered to undergo treatment used 
significantly more outpatient counseling than women who were not under court-order.      
 There were significant differences in the extent to which IC affected use of 
residential substance abuse treatment at follow-up depending on the presence or absence 
of unmet need for targeted IC services.  When the presence or absence of unmet need was 
modeled according to treatment group and symptom severity, among women in the class 
with unmet need for IC, those in the IC study group used significantly more days of 
residential treatment by 12 months than women in the usual care group IC (β = 0.196, 
p<.001).  Women with unmet need who were in the IC group had a predicted average of 
106.50 (SD = 100.24) days in residential treatment at 12 months as compared to 86.95 (SD 
= 77.25) days among women with unmet need who were in the usual care group. 
 When the latent classes generated according to unmet need for IC were 
determined by treatment group and baseline service use patterns, the model for residential 
substance abuse treatment also indicated distinct effects of IC for women with an unmet 
need for targeted intervention services.  The sub-group of women with unmet need who 
were in the IC group spent a statistically significantly greater number of days in residential 
treatment than women with unmet need who were in the comparison group (β = 0.189, 
p<.001).   The predicted number of days spent in residential treatment over 12 months’ 
follow up was 119.82 days (SD = 91.63) among those women in the IC group versus 93.12 
days (SD = 71.91) among women in the comparison group. 
 Models that used both baseline symptoms and service use to estimate the 
probability of having an unmet need for care produced similar results for the effect of IC on 
residential treatment use at follow-up.  Women in the IC group who had unmet need for care 
spent more days in residential treatment than women in the comparison group who had 
unmet need for care (β = 0.190, p<.001), and the predicted number of days of treatment was 
119.33 (SD = 90.72) and 94.85 (SD = 71.30), respectively (Table 17).   
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 For external medical costs, there were no statistically significant differences in IC 
effect between women in the unmet need sub-group and women in the sub-group without 
any unmet need for IC when the latent classes were estimated according to treatment group 
assignment and baseline symptom severity.  There were, however, significant differences in 
IC effects on external medical costs when the latent classes were generated according to 
treatment group assignment and service use patterns at baseline.  Among women with no 
unmet need for IC services, women in the IC group had higher expenditures for medical 
care at 12 months than women in the usual care group (β = 302.56, p<.05).  Furthermore, 
having a physical illness or disability and having some type of medical insurance had 
positive effects on follow-up external medical expenditures for women with no unmet need, 
but did not have significant effects for the class of women who had unmet need for IC.   
 Similar effects of IC on external medical costs were estimated for classes based on 
treatment assignment, symptoms and service use.  Among women who did not have an 
unmet need for IC, those in the IC group had higher expenditures at follow-up than women 
in the usual care group (β = 282.80, p<.05) (Table 18).  Among women with no unmet need 
for IC, relatively higher levels of psychotropic medication costs and residential treatment use 
were associated with modest increases in external medical costs at 12 months’ follow-up.  
Also among women with no unmet need for IC, having a serious illness or disability and 
having medical insurance were both associated with higher medical costs than women 
without illness or insurance.   
  The two-class models for latent effects of IC on total overall costs indicated that 
there were no significantly different effects among participants with an unobserved unmet 
need for IC treatment as compared to women with no unmet need, across each of the three 
classifying approaches (Table 19).  There was, however, a significant positive association 
between drug addiction severity scores and overall costs at 12 months among women who 
had no unmet need for IC.  Among women who had an unmet need for IC, women in the 
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Other race category and women who had less than a high school education had lower 
overall costs than White women and women who had completed high school.   
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CHAPTER 6
DISCUSSION 
 
 Existing evidence suggests that, on average, IC is more effective for improving 
clinical functioning than usual care without a significant increase in costs (Cocozza et al., 
2005; Morrissey et al., 2005a; Morrissey et al., 2005b; Domino et al., 2005a; Domino et al., 
2005b).  However, estimates of the average effect of IC mask important variations in 
symptom severity and service use and cost patterns among people who engage in IC that 
can influence the intervention’s effectiveness.  The present analyses added important 
evidence by uncovering heterogeneous effects of integrated counseling among different 
types of women who participated in WCDVS.  The clustering methods used here generated 
two sets of parsimonious, data-driven sub-groups – one by baseline symptom severity and 
another by baseline service utilization patterns.  Each approach to categorization provided 
important unique information about how IC works differently for different sub-populations.  
Sub-groups were also generated using latent class analysis as a comparative approach and 
as a means for assessing the effects of limitations of cluster analysis limitations on these 
analyses. 
 While the study results indicate that the majority of women in the analytic sample had 
similar outcomes for service use and costs, there is evidence that there were, indeed, 
significant differences in the effect of IC on outcome service use and costs for certain sub-
groups of women in the study population.  This evidence about heterogeneous effects of IC 
provides important information for clinical practice, program design and delivery, and policy.  
By understanding how IC works in different sub-populations, this intervention can be 
optimally targeted to women for whom it works best, and continued/new efforts can be made 
to help women for whom IC is not as effective.   
 Women who were characterized as having low symptom severity at baseline and 
who were in the IC group appeared to have used services inefficiently, as they had relatively 
high levels of residential treatment use and external medical costs as compared to their 
counterparts in the usual care group.  Cusack and colleagues’ sub-group analysis found no 
change in clinical symptoms among women with low symptom severity at baseline, though 
their cluster assignments were not exactly the same as those generated in these analyses.  
Nevertheless, the two separate study findings for the effect of IC among women with low 
symptom severity may indicate that, on average, women with this symptom profile were not 
using services efficiently upon receiving IC.  Joint analyses of clinical and service outcomes 
among women with low baseline symptom severity would be useful to learn more about the 
efficiency of their service use.      
 Women in the moderate-to-severe PTSD group who were in IC also appeared to use 
services inefficiently at follow-up.  They may have underutilized IC counseling services after 
initiating participation in the intervention considering that they used counseling less 
intensively than their counterparts in the usual care group and this counseling was the 
primary service of the intervention.  Isolating this effect in this particular symptom sub-group 
suggests not that integrated counseling does not work for them, but that they are 
underutilizing the intervention services.  This may indicate that more intensive and sustained 
outreach is needed for women whose predominant symptom is moderate-to-severe PTSD to 
encourage them to fully engage in IC services in the hopes of improving their clinical 
outcomes and other areas of functioning. 
 Less clear are the implications of women in the moderate-to-severe PTSD group 
who were in IC being less likely to have any external medical costs than women with 
moderate-to-severe PTSD who were in the usual care group.  It is possible that a lower 
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likelihood among these women of having any external medical costs indicated that they 
were substituting the use of more appropriate services that were intended to treat their 
particular complex set of disorders (e.g., peer support, case management) for use of crisis 
or medical services (e.g., hospital stays, ER visits), thereby reducing the costs associated 
with their care.   
 More likely, arguably, is that women with moderate-to-severe PTSD were generally 
underutilizing services, given that they used relatively little counseling and that they were 
relatively likely to have no medical costs at all.  This implies that IC outreach efforts may 
need to more effectively target women who suffer predominantly from moderate-to-severe 
PTSD and who are not yet engaged in IC.  Among women with this disorder profile who 
have already initiated IC, on the other hand, these results suggest that more intensive case 
management could help ensure that they maintain consistent and sustained use of IC 
services, and thereby increase their chances of achieving improved outcomes.  It is also 
important to note that outreach and case management may need to be intensified for Black 
women in this population, as well.  They, like women whose predominant symptom was 
moderate-to-severe PTSD, used counseling services less intensively than White women and 
were less likely to have any external medical costs.   
   A promising result of these analyses was evidence of relatively lower medical costs 
among women with high-severity drug addiction and moderate-to-severe PTSD who were in 
the IC group as compared to the same women in the usual care group.  Here, too, the 
relative reduction in medical costs may indicate that these women reduced their use of 
inappropriate or sub-optimal services for treating their disorders (e.g., hospital stays, ER 
visits).  This interpretation of the effect of IC among this sub-group of women is supported by 
evidence from the sub-group analyses by Cusack and colleagues that found significant 
improvements in PTSD symptoms associated with the intervention among women with co-
morbid substance abuse and PTSD as the predominating symptoms at baseline.  However, 
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without direct connections between medical costs and clinical symptoms among this 
particular analytic sub-group of women, it is not possible to impose a value judgment on the 
change in medical costs.  With that in mind, clinical improvements among these women 
could potentially accompany reductions in costs if they were encouraged to participate more 
intensively in outpatient counseling and other targeted IC services. 
 The trend of lower costs after IC was even more pronounced among women who 
were in the high alcohol severity group at baseline, as women in this sub-group in IC had 
relatively low medical and overall costs as compared to women in the same symptom sub-
group who were in the usual care group.  This may also reflect their having shifted away 
from use of potentially inappropriate, resource-intensive services, and instead having 
substituted them with targeted IC service, particularly in light of the findings by Cusack and 
colleagues.  However here, too, it is not possible to draw absolute conclusions about the 
benefit of the reduction in costs without coincident improvements in clinical symptoms for 
this specific analytic sample.  Significantly higher overall costs among women on this sub-
group who reported that they were currently in an abusive situation than those who were not 
may be an important indication that IC is not fully effective in terms of cost reduction for 
women who are being abused while engaged in treatment.  For this reason and in the 
interest of overall welfare, IC treatment for women currently in abusive situations should 
include special measures to address acute needs to assure victims’ safety and achieve 
stability.   
 The integrated counseling intervention appeared to be particularly effective in its 
effect on use of residential substance abuse treatment for certain sub-groups of participants.  
Women who were low-intensity services users and in IC used more residential treatment at 
follow-up than their counterparts in the usual care group.  This may indicate that these 
women in the IC group were using residential treatment more efficiently after engaging in 
the intervention if they, in fact, had been underutilizing the service previously.  
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 Integrated counseling also reducing use of residential substance abuse treatment 
among the sub-group of women who reported using residential treatment intensively at 
baseline as compared to women with the same baseline service characteristic who were 
received usual care.  While a definitive conclusion about the appropriateness of reductions 
in use of residential treatment among women who were heavy users of residential treatment 
is not evident, their decrease in use of residential treatment is likely a positive effect of IC.  
Residential treatment, while at times necessary, is highly resource intensive (Dickey and 
Azeni, 1996; Barnett and Swindle, 1997; Roebuck et al., 2003) and interrupts women’s lives 
and roles in their communities.  Use of targeted outpatient services to control substance 
abuse symptoms is arguably much better for the women and for cost savings than 
residential treatment.  
 Another promising result of these analyses is the effect of IC for the sub-group of 
women who were high-intensity users of counseling at baseline.  These women used fewer 
days of residential treatment at follow-up as compared high-intensity counseling users who 
received usual care.  Here, too, the implication is that women substituted targeted, less 
intensive services for residential treatment.  The benefits of this effect extend beyond the 
reduced use of a resource-intensive service and clinical improvements for these women.  
Fewer days spent in residential treatment for these women translates to more days spent in 
the community and fewer interruptions in their fundamental roles as parents, participants in 
the workforce, and other positive, meaningful activities.   
 The results from the LCA models supported the results from cluster-approach 
models for two outcomes, residential treatment and external medical costs, but generated 
null results for counseling and overall costs.  For the sake of parsimony and ease of 
interpretation, the LCA model results in which both baseline symptoms and service use 
were used to estimate the probability of having an unmet need for care are discussed here.   
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 Similar conclusions can be drawn from the LCA and cluster models for the effect of 
IC on outcome residential treatment use.  Among women in IC, those with an unobserved 
unmet need for care (i.e., women in the low-intensity service use cluster at baseline) used 
more residential treatment at follow-up than women with no unmet need for care (i.e., 
women in the high-intensity residential treatment use cluster at baseline).  The LCA model 
and cluster models both demonstrated that similar types of women had relatively low 
external medical costs.  The LCA model characterized these women as having an 
unobserved unmet need for care, while according to the cluster analysis models, these 
women were characterized as having high severity symptoms – either moderate-to-high 
PTSD severity, high drug and moderate-to-severe PTSD severity, or high alcohol severity.   
 The LCA model results for outpatient counseling and total overall costs differed from 
the cluster model results, as the LCA models for both of these outcomes did not 
demonstrate significant effects for either latent class.  The differences in results between the 
cluster approach and the LCA approach likely reflect different sub-groups of women in the 
respective models’ clusters and latent classes, for each of whom IC had unique effects on 
the outcomes.  It is also possible that if LCA models with three or more classes could have 
been estimated, they would have been more comparable to the sub-groups generated using 
cluster analysis and may have produced IC effects that were consistent with the cluster 
models.      
 
Strengths and limitations 
There are many important strengths of the study design and analyses conducted for 
this dissertation.  A primary strength of this dissertation is the identification of heterogeneous 
effects of the IC intervention within a larger population of women with co-occurring disorders 
and histories of abuse.  The assumption of a homogeneous treatment response is often 
unreasonable without empirical evidence to support it (Manski, 2001).  Therefore, differential 
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treatment response should be estimated in an effort to work toward maximizing the benefits 
of treatment for women in this larger population.  Both average effects of IC within the 
population and sub-group effects of IC according to defining characteristics can help 
policymakers understand how IC works in the population at large, as well as for whom 
specifically it is most and least effective.   
The intent-to-treat analytic approach used in this study generated results that reflect 
how IC actually worked in this population versus how IC could potentially work if all study 
design conditions were fulfilled.  Therefore, the intent-to-treat approach provided a more 
realistic picture of how effective IC was in its real-world application.  This approach gives 
care providers, outreach coordinators, and policymakers important information that can help 
them optimize the access, delivery, and effectiveness of services for women with co-
occurring disorders and histories of abuse.   
Another important strength is this study’s contribution to improving the categorization 
of people with co-occurring disorders, particularly women in this study population, in an 
effort to identify sub-groups in as representative and meaningful a way as possible.  I 
employed cluster analytic methods to derive distinct sub-groups and build on the existing 
quadrant model.  The quadrant model divides people into four symmetrical categories, 
which is likely not representative of the way complex symptoms actually manifest.  Cluster 
analysis also improves upon the quadrant model by accounting for possible PTSD, thereby 
generating clusters based on multiple dimensions and accommodating complex 
combinations and interactions of symptoms.  The more accurately we can identify sub-
groups of people with complex disorders, the more likely we are to understand how 
treatment works for them in hopes of improving their symptoms and the quality of their lives. 
   The clustering methodology used here also added to the strength of the study.  
Having used a combination of multi-step cluster methods improved the accuracy of 
identifying the number of distinct clusters and the assignment of data points to those 
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clusters as compared to using a single method.  Having conducted several iterations of 
cluster analyses, specification tests and sensitivity analyses added important support for 
final clustering solutions that were used.  In addition, evaluating sub-group effects of IC 
using LCA in addition to cluster analysis provided important support to the robustness of our 
evidence regarding how IC changed outcome service use and costs differentially for certain 
sub-groups of study participants. 
 There are several limitations to this study that are important to consider.  First, a 
quasi-experimental study design can introduce biases, e.g., unbalanced treatment groups 
and differential attrition.  In the case of WCDVS, it would have been near impossible to 
achieve the benefits of random assignment, as the intervention condition would almost 
certainly carry over into services provided to control group participants within the same 
agencies.  Also, care providers expressed ethical concern about withholding trauma-
informed elements of care from any participants  (McHugo et al., 2005).   
 The quasi-experimental study design generated intervention and comparison groups 
that were not perfectly balanced, as White women, Black women, and women court-ordered 
to receive treatment were more likely to be in the integrated counseling group than the 
comparison group.  Also, there was differential attrition at 12 months based on age, race, 
education level, and symptom severity; however, there was no differential attrition between 
the IC and comparison groups.  The benefit of non-random recruitment is that the study 
groups it generated were more representative of women who, in the real world, may migrate 
to targeted IC services and others who remain in settings where they receive usual care. 
 Secondly, making the assumption that treatment assignment was the equivalent of 
treatment receipt may have biased results if participants in the control group were actually 
receiving IC-type services.  However, this would attenuate the effect, biasing the estimate 
downwards. In this case, estimates would then be too conservative versus overstated.  
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 There are strengths to be gleaned from the limitations of the quasi-experimental 
design.  By understanding its inherent limits for making counterfactual inferences about 
treatment effect, as discussed above, one can avoid common pitfalls in the assumptions one 
makes about experimental study results.  Common assumptions made about studies using 
random assignment include expectations that the study sample is representative of the 
larger population to which the investigator hopes to generalize his results; that there is 
perfect, or at least equal, compliance in all study arms; that the absence of circumstances in 
the social context in the experimental setting will extend to the natural setting if the program 
is implemented on a large scale; and that there is no variation in treatment across the study 
population (Manski 1996, Manski 2000).  These conditions seldom exist in a real-world 
setting, and have been acknowledged here in interpreting the results.  Furthermore, the sub-
group analysis presented in this dissertation avoids and disproves the assumption that the 
average treatment effect is the same for all people within the study population, an arguably 
important contribution to the understanding of how IC works in this population of people.     
 Thirdly, an important limitation of cluster analysis is that there is no definitive way to 
ascertain the true number of clusters that exist in the data.  Instead, this step in the 
clustering process depends on the judgment of the investigator.  This shortcoming of the 
method was mitigated by use of specification tests, as well as several other analytic tools for 
assessing the sensitivity of the cluster results.  This included conducting several iterations of 
the clustering process using different variable scaling approaches, re-generating effect 
estimates after combining similar clusters to detect any differences in the effect of IC on sub-
groups of study participants, and using LCA as a comparative methodological approach to 
identifying sub-groups in this study population.  Also, one of the assumptions of cluster 
analysis is that the input variables have normal or Gaussian distributions.  Considering that 
the variables used for clustering in this study had non-normal distributions, the violation of 
that assumption could have biased effect estimates.  The use of LCA as a comparative 
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approach to generating sub-groups of women in this population provides a means for 
assessing consistency of results, and thereby mitigates the potential concern of non-normal 
clustering variables to some extent.               
 Fourth, there were limitations in the modeling of LCA for this dissertation.  Firstly, the 
finite mixture modeling function in Stata® v10 software does not support zero-inflated 
negative binomial distributions, and so a negative binomial distribution was estimated 
instead for counseling and residential treatment outcomes.  The large proportion of zeros for 
each of these outcome variables was therefore not accounted for in the model.  In addition, 
models with more than two latent classes would not converge, and so it was not possible to 
compare the goodness of fit of two-class models with multi-class models.  It was beyond the 
scope and resources of this study to use specialized software for latent class analyses, 
however, additional work on latent class models using specialized software would be a 
useful contribution to future analyses of the heterogeneous effects of integrated counseling.   
 Finally, another limitation of the study analyses is the possibility that endogeneity 
bias was introduced in the study models by the explanatory variable indicating whether 
participants had any insurance versus none.  This variable would be endogenous if it not 
only predicted a given outcome variable, but if the outcome variable also predicted whether 
or not a participant had insurance.  That circular causality, if present, would bias effect 
estimates.  The risk of endogeneity seems most likely in the case of residential substance 
abuse treatment, as use of the service may be contingent on having insurance due to the 
high cost.   
 Endogeneity bias due to the insurance variable is arguably not present in these 
analyses for two reasons.  Model estimates of the effect of IC on outcomes were not 
significantly different when re-run without a control for insurance status.  While this study 
sample comprised a variety of women for whom IC may have worked differently, it also was 
relatively homogeneous, in a broader sense, in its being a unique sub-set of people with co-
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occurring disorders who had many shared circumstances affecting their access and use of 
medical insurance.  This aspect of the data likely minimized any endogenous effect of 
insurance status.  Also, the presence of a covariate for the presence of serious physical 
illness or disability is an exogenous variable that is likely accounting for some of the unique 
effect of insurance status.           
  
Future research opportunities  
 Future analyses would continue to build our understanding of how and why some 
sub-groups of women participating in WCDVS responded better to IC than others.  For 
example, it would be helpful to look more closely at social functioning and supports, 
predisposing and enabling factors associated with their use of services, and perceived need 
for care among women for whom IC was relatively ineffective to identify potential barriers to 
their using and benefiting from services that are intended for their unique needs.  An 
example of two important social factors to consider that may have inhibited some women’s 
engagement in IC treatment are homelessness and whether they were residing in domestic 
abuse shelters during the study period.  Possible analyses to explore these associations 
include clustering women according to these baseline characteristics to estimate differential 
treatment effect. 
 In addition, further analyses should be conducted to understand more about changes 
in service use and costs after receiving IC among women in the high baseline 
drug/moderate-to-severe PTSD cluster and women in the high baseline alcohol cluster.  
This would provide more insight into their relatively large reductions in external medical 
costs and overall costs, and how it coincided with their use of IC services other than 
outpatient counseling.  This could include modeling the effect of IC on follow-up use of 
inpatient counseling, peer support services, and case management among these sub-
groups of women.  
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 Another potential set of analyses would be to understand more about the sub-groups 
of women identified in this study who responded well to IC.  Specifically, among women for 
whom IC was relatively effective, it would be interesting to analyze additional outcomes to 
determine if/how IC improved other aspects of their lives (e.g., labor force participation, 
improved housing situation, use of domestic violence shelters) in addition to their clinical 
symptoms and service use and costs.    
 
Implications for practice, policy, and research 
 The findings presented here provide important information for both practitioners and 
policy-makers.  Several types of practitioners – including medical, mental health, substance 
abuse treatment providers – can quite easily identify women who use high levels of 
counseling for co-occurring disorders, a sub-population for whom IC was particularly 
effective, and encourage them strongly to engage in IC treatment.  Identifying women by 
asking them about their service use is much more practically feasible than assessing several 
complex dimensions of symptom severity, particularly for practitioners without the diagnostic 
skills and resources necessary to conduct symptom assessments.  So, this new evidence 
presented here creates a particularly good opportunity for care providers to find the women 
for whom IC works well.     
 These results also suggest that professionals involved in the planning, delivery, and 
administration of integrated counseling may need to improve outreach and case 
management for women in this population who suffer predominantly from moderate-to-
severe PTSD, and encourage them to use IC-specific counseling more intensively in an 
effort to improve their clinical functioning.   
 Finally, alternatives should be explored and evaluated for women in this population 
with low-level baseline symptoms, as they had higher levels of service use and costs at 
follow up then several other sub-groups and therefore may be using services inefficiently.  It 
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is important to understand why these women continue to have relatively high levels of 
utilization of inpatient hospital stays, ED visits, and outpatient medical care even though 
they are engaged in targeted IC services.  Additional resources should be dedicated to 
developing and evaluating interventions that are cost-effective for women with this symptom 
profile to optimize their use of effective, efficient services and reduce their use of medical 
care.   
 This study provides important information about how effective IC is for different sub-
populations of women with co-occurring disorders and histories of abuse.  The evidence 
presented here reveals for whom the intervention appears to be most effective, and for 
whom treatment effectiveness could still be improved.  By responding to the unique needs of 
sub-groups of women in this population, we can reduce their inappropriate use of resource-
intensive medical services and increase their use of targeted, integrated care in an effort to 
improve clinical functioning, enhance quality of life, and achieve a more efficient expenditure 
of constrained public resources.  
 Tables
 
 
 Table 1. Dependent variables:  Service use and costs 
  Variables Measure(s) Proposed 
Operationalization 
(V1) Outpatient 
counseling use 
- Individual and/or 
group counseling 
 
 
 Number of visits 
 
Total number of counseling visits aggregated 
across 12 months of follow up 
   
(V2) Residential 
treatment use  
 
Number of days 
 
Sum of days used across 12 months of follow up 
 
   
(V3) External medical 
costs 
- Outpatient medical 
visits 
- Hospital days 
- ER visits 
 
 
 
Total cost per service 
 
 
Sum of number of days/visits x average cost per 
service, aggregated across 12 months of follow up 
(V4) Total costs Total cost of all types 
of services reported 
Sum of number of days/visits x average cost per 
service, aggregated across 12 months of follow up 
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  Table 2. Baseline Sample Characteristics by Intervention/Comparison Group  
 Overall study sample (N = 2,001) 
 
Intervention Sites 
(N = 999) 
 
 
Comparison Sites
(1,002) 
 
Age    36.7 36.6 36.7
Race     
White   
    
   
56.8% 54.2%* 59.4%
African American 27.1% 31.9%** 22.3% 
Hispanic 17.2% 16.6% 17.9%
Other 18.3% 17.4% 19.3%
Education – mean # years  11.6 
 
11.5 
 
 
11.7 
 
Physical illness or disability  50.9% 50.0% 51.9% 
Currently at risk for abuse 71.9% 73.4% 70.4% 
Any health insurance 69.9% 69.7% 70.0% 
Court-ordered treatment 33.8% 
 
37.9%** 
 
29.7% 
Perceived unmet need for care 43.5% 
 
41.9% 
 
 
45.1% 
 
  Z-score probabilities for intervention versus comparison group calculated for each variable using logistic regression;  
 * significant at 5% level; ** significant at 1% level 
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  Table 3. Baseline mean values (SD) for symptom severity clustering variables   
 Rescaled values    
(0 – 100) 
  
Raw scale values 
Variable   Mean SD  Mean SD Range
Addiction Severity Index - 
Alcohol 
  20.18   03.19    0.20   0.30 0 – 1 
Addiction Severity Index - 
Drugs 
  16.90   15.59    0.17   0.16 0 – 0.70 
Post-traumatic Symptom 
Scale 
  46.17   22.89  23.94 11.77 0 - 51 
       n = 2,729 
 
 
 Table 4. Baseline mean values (SD) for service use/cost clustering variables 
  
Percent 
with any 
use/costs 
 
Rescaled values  
(0 – 100) 
  
Raw scale values 
Variable   Mean SD  Mean SD 
Outpatient counseling visits 65.22%      8.62  12.73       20.18     29.78 
Psychotropic medication 
costs  
62.77% 
 
   15.57  16.33     361.90   379.65 
Residential Tx days 
 
52.42%    15.55  22.54       18.66     27.05 
External medical costs 
 
75.26%      1.99    5.56  3,173.75 8880.30 
              n = 2,729 
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  Table 5. Symptom clusters: baseline mean values (SD) for input variables  
 Cluster   → C1-Sx C2-Sx C3-Sx C4-Sx C5-Sx C6-Sx C7-Sx
N 368 431 355 222 164 201 260
Addiction Severity Index - 
Alcohol 
1.81 1.60 1.52 5.11 40.39 41.61 83.85
Addiction Severity Index - 
Drugs 
10.79 8.03 13.37 38.09 15.84 12.28 26.78
Post-traumatic Symptom 
Scale  
16.11 43.15 73.01 46.34 72.16 31.75 51.72
             n = 2,001   
 
 
 Table 6. Service use/cost clusters: baseline mean values (SD) for input variables  
 Cluster   → C1-Serv C2-Serv C3-Serv C4-Serv C5-Serv
N 777 314 246 250 414
Counseling visits 4.68 2.50 33.80 6.00 9.56
Psychotropic medication 
costs 
8.21 6.28 11.75 15.55 40.03
Residential Tx days 3.02 27.32 4.94 69.68 5.19
External medical costs 1.34 1.59 1.25 1.89 3.61
              n = 2,001  
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 Table 7. Distribution of participants (n) across symptom and service clusters 
  
C1-
Serv 
C2-
Serv 
C3-
Serv 
C4-
Serv 
C5-
Serv Total 
C1-Sx 172 70 46 45 35 368 
C2-Sx 176 42 69 49 95 431 
C3-Sx 135 28 46 22 124 355 
C4-Sx 65 62 15 37 43 222 
C5-Sx 58 16 22 22 46 164 
C6-Sx 88 36 30 23 24 201 
C7-Sx 
83 60 18 52 47 260 
Total 777 314 246 250 414 2,001 
n = 2,001; χ2 = 192.166, p<.001      
 
 
 
 Table 8. Summary of significant effects (95% confidence intervals) for IC v. usual care: symptom cluster regression modelsa
  
Outpatient 
counselingb
Residential 
treatmentb External medical costsc Total overall costsd
Low symptom severity (C1-Sx) 
― 0.363          
(0.167, 0.559) 
― ― 
Predominant PTSD (moderate) 
(C2-Sx) 
-0.381           
(-0.697, -0.065) ― ― ― 
Predominant PTSD (severe) 
(C3-Sx) 
― ― ― ― 
Comorbid Drug (severe) & 
PTSD (moderate) (C4-Sx) 
― ― -7,458.706               (-13,957.404, -960.016) ― 
Comorbid PTSD (severe) & 
Alcohol (moderate) (C5-Sx) 
― ― ― ― 
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 Comorbid PTSD (moderate) & 
Alcohol (moderate) (C6-Sx) 
― ― -7,495.390               (-13,453.561, -1,537.219) 
-12,882.548              
(-24,762.077, -1,003.020) 
Comorbid Alcohol (severe) & 
PTSD (moderate) (C7-Sx) 
― ― ― ― 
 a n = 2,001; All models controlled for individual- and program-level covariates.  Only coefficients and confidence intervals that were 
 statistically significant at the 95 percent level are reported here.  b Zero-inflated negative binomial models.  c Two-part model, logit for 
probability of any costs, OLS for level of costs for those with any costs. d Ordinary least squares (OLS) model. 
 
 
 
 Table 9. Summary of significant effects (95% confidence intervals) for IC v. usual care: service cluster regression models a
  
Outpatient 
counselingb
Residential 
treatmentb External medical costsc Total overall costsd
Low service use (C1-Serv) 
― 0.395           
(0.219, 0.571) 
― ― 
Moderate residential treatment 
days (C2-Serv) 
― ― ― ― 
High counseling use (C3-Serv) 
― -0.384           
(-0.733, -0.035) 
― ― 
High residential treatment 
days (C4-Serv) 
― -0.303           (-0.560, -0.046) ― ― 
High psychotropic drug & 
external medical costs (C5-Serv) 
― ― ― ― 
 a n = 2,001; All models controlled for individual- and program-level covariates.  Only coefficients and confidence intervals that were 
 statistically significant at the 95 percent level are reported here.  b Zero-inflated negative binomial models.  c Two-part model, logit for 
probability of any costs, OLS for level of costs for those with any costs. d Ordinary least squares (OLS) model. 
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  Table 10.  Effect of IC on 12-month counseling visits by clustera,b
       
Symptom clusters         
 
 
 
Coefficient 
(SE) 
 
 Service clusters           
 
 
 
Coefficient 
(SE) 
    
(Reference group – Low alcohol,      
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 --  (Reference group – --
Average drug, Low PTSD (C1-Sx)) 
 
--
 
Low service use (C1-Serv)) 
 
--
 
Moderate/Severe   0.173      Moderate residential treatment  -0.052     
PTSD (C2-Sx)  (0.114)  days (C2-Serv) 
 
 (0.14) 
   
Severe PTSD,   0.123      High counseling   0.519** 
Moderate Drug (C3-Sx)  (0.121) 
 
 use (C3-Serv)  (0.130) 
   
Moderate/Severe PTSD,   0.190      High residential treatment   0.071     
Severe Drug (C4-Sx)  (0.14) 
 
 days (C4-Serv)  (0.138) 
   
Severe PTSD, Moderate/Severe  -0.057      High psychotropic drug &   0.144     
Alcohol, & Drugs (C5-Sx)  (0.152)     
 
 external medical costs (C5-Serv) 
 
 (0.133) 
  
High alcohol (C6-Sx) 
 
  0.047     
 
    
(0.14)
 
High alcohol/Drug (C7-Sx) 
 
  0.081     
 
    
(0.133)
 
IC treatment group 
 
  0.107     
 
 IC treatment group 
 
  0.025     
 (0.122)
 
(0.121)
 
Moderate/Severe 
PTSD (C2-Sx) x IC 
 
 
-0.381* 
(0.161) 
 
 
Moderate residential treatment 
days (C2-Serv) x IC 
  0.134     
 (0.233) 
 
 Severe PTSD,   0.142      High counseling   -0.158     
Mod Drug (C3-Sx) x IC 
 
 (0.168) 
 
 use (C3-Serv) x IC 
 
 (0.175) 
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Moderate/Severe PTSD,  -0.125      High residential treatment  -0.091     
Severe Drug (C4-Sx) x IC 
 
 (0.200) 
 
 days (C4-Serv) x IC 
 
 (0.184) 
   
Severe PTSD, Moderate/Severe   0.390      High psychotropic drug &   0.163     
Alcohol, & Drugs (C5-Sx) x IC 
 
 (0.209)  external medical costs   (0.167) 
 (C5-Serv) x IC     
High alcohol (C6-Sx) x IC 
 
 -0.043     
 
    
(0.207)
  
High alcohol/Drug (C7-Sx) x IC 
 
 -0.362       
  (0.226)
    
Age   0.0000 
 
 Age  -0.002     
  (0.003)
 
 (0.004)
   
Hispanic  -0.002     
 
 Hispanic   0.016     
  (0.085)
 
 (0.11)
   
Black -0.258** Black
 
-0.255**
  (0.074)
 
 (0.082)
   
Race-Other  -0.202**  Race-Other
 
 -0.21*
  (0.078)
 
  (0.092)
    
Less than 
high school 
 
 
-0.238**  Less than  -0.204* 
(0.064)  high school 
 
 (0.083) 
   
College  -0.245**
 
 College
 
 -0.202*
 (0.070) (0.087)
 
        
   
   
   
   
   
    
   
    
   
   
       
    
Illness/disability  -0.008     
 
 Illness/disability  -0.008     
  (0.055)
 
 (0.062)
   
Current abuse   0.011      Current abuse   0.061     
    (0.060)
 
(0.066)
   
Any insurance   0.096      Any insurance 
 
  0.088     
   (0.063) (0.082)
   
Court-ordered 
 
 0.203**
 
 Court-ordered
 
 0.223**
treatment
 
(0.058)
 
treatment
 
(0.072)
 
Perceived unmet need  -0.012      Perceived unmet  -0.033     
for care  (0.053) 
 
 need for care 
 
 (0.062) 
  
Constant  4.867**
 
Constant
  
 4.872
  (0.179) (0.226)**
n = 2,001; Robust standard errors in parentheses; * significant at 5%; ** significant at 1%;  
a Zero-inflated negative binomial models. bAll models controlled for site-level fixed effects.   
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  Table 11.  Effect of IC on 12-month residential treatment days by clustera 
       
Symptom clusters         
 
 
 
Coefficient 
(SE)  Service clusters           
 
  
Coefficient 
(SE)
    
(Reference group – Low alcohol,        
     
   
   
   
   
   
   
   
     
      
     
      
   
     
 82
-- (Reference group – --
Average drug, Low PTSD (C1-Sx)) 
 
--
 
Low service use (C1-Serv)) 
 
--
Moderate/Severe 
 
  0.025     
 
 Moderate residential treatment 
 
  0.138     
 PTSD (C2-Sx) (0.106) days (C2-Serv)
 
(0.078)
   
Severe PTSD,  -0.011      High counseling    0.069     
Moderate Drug (C3-Sx)  (0.124) 
 
 use (C3-Serv)  (0.126) 
   
Moderate/Severe PTSD, 
 
 -0.016     
 
 High residential treatment 
 
  0.107     
 Severe Drug (C4-Sx) (0.101)
 
days (C4-Serv) (0.09)
   
Severe PTSD, Moderate/Severe   0.103      High psychotropic drug &   0.012     
Alcohol, & Drugs (C5-Sx)  (0.169) 
 
 external medical costs (C5-Serv) 
 
 (0.107) 
  
High alcohol (C6-Sx) 
 
  0.139     
 
    
(0.101)
 
High alcohol/Drug (C7-Sx) 
 
  0.084     
 
    
(0.096)
 
IC treatment group 
 
  0.363** 
 
 IC treatment group 
 
  0.395**     
 (0.100)
 
(0.090)
 
Moderate/Severe  -0.042      Moderate residential treatment  -0.158     
PTSD (C2-Sx) x IC  (0.143)  days (C2-Serv) x IC  (0.113) 
 
      
   
   
   
     
      
      
      
   
     
     
   
    
     
   
     
    
     
    83
  
Severe PTSD,  -0.109      High counseling   -0.384* 
Mod Drug (C3-Sx) x IC  (0.17) 
 
 use (C3-Serv) x IC  (0.178) 
   
Moderate/Severe PTSD,  -0.082      High residential treatment  -0.303* 
Severe Drug (C4-Sx) x IC  (0.139) 
 
 days (C4-Serv) x IC  (0.131) 
   
Severe PTSD, Moderate/Severe  -0.275      High psychotropic drug &   0.082     
Alcohol, & Drugs (C5-Sx) x IC  (0.218) 
 
 external medical costs  
 
 (0.154) 
  (C5-Serv) x IC
High alcohol (C6-Sx) x IC 
 
 -0.130     
 
    
(0.172)
 
High alcohol/Drug (C7-Sx) x IC  -0.060     
 
    
(0.137)
 
Age   0.001     
 
 Age   0.001     
  (0.003)
 
 (0.003)
 
Less than  -0.053     
 
 Less than  -0.057     
 high school (0.055)
 
high school (-0.055)
   
College  -0.116     
 
 College  -0.122* 
 (0.06)
 
 (0.059)
 
Illness/disability   0.011     
 
 Illness/disability  -0.019     
  (0.044)
 
 (-0.048)
 
Current abuse 
 
  0.017     
 
 Current abuse   0.004     
(0.049)
 
 (-0.048)
 
 
 Any insurance   0.049     
 
 Any insurance   0.048     
     
     
   
   
   
   
(0.051)
 
 (-0.051)
 
Court-ordered 
 
  0.086     
 
 Court-ordered 
 
  0.087     
 treatment
 
(0.045)
 
treatment
 
(-0.046)
 
Perceived unmet need 
 
 -0.011     
 
 Perceived unmet need 
 
 -0.005     
 for care
 
(0.045)
 
for care
 
(-0.044)
 
Constant   4.588**      Constant   4.573**     
   (0.134)      (0.130) 
n = 2,001; Robust standard errors in parentheses; * significant at 5%; ** significant at 1%;  
a Zero-inflated negative binomial models.     
  
 
 
Table 12.  Effect of IC on 12-month external medical costs by symptom clustersa,b 
     
Logit  OR (SE)  OLS  
 Coefficient 
(SE)
      
(Reference group – Low alcohol,       
  
    
   
   
     
   
    84
-- (Reference group – Low alcohol,  --
Average drug, Low PTSD (C1-Sx)) 
 
  --  Average drug, Low PTSD (C1-Sx)) 
  
  -- 
 
Moderate/Severe 
 
 1.333  Moderate/Severe 
 
  2,381.344     
 PTSD (C2-Sx)
 
(0.574)
 
PTSD (C2-Sx)
 
(1359.964)
 
Severe PTSD,  1.437  Severe PTSD,   508.993     
Moderate Drug (C3-Sx)  (0.68) 
 
 Moderate Drug (C3-Sx)  (1304.895) 
   
Moderate/Severe PTSD, 
 
 1.341  Moderate/Severe PTSD, 
 
   6277.392* 
Severe Drug (C4-Sx)
 
(0.696)
 
Severe Drug (C4-Sx) (2,945.182)
  
 
  
Severe PTSD, Moderate/Severe  2.879  Severe PTSD, Moderate/Severe   779.923     
Alcohol, & Drugs (C5-Sx)  (2.272) 
 
 Alcohol, & Drugs (C5-Sx)  (1713.066) 
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High alcohol (C6-Sx) 
 
 1.37  High alcohol (C6-Sx) 
 
   5545.435* 
(0.646)
 
(2,471.531)
 
High alcohol/Drug (C7-Sx) 
 
 1.097  High alcohol/Drug (C7-Sx) 
 
  1,472.845     
 (0.489)
 
(1512.748)
 
IC treatment group 
 
 3.321*  IC treatment group 
 
  1,470.237     
 (1.703)
 
(1265.037)
 
Moderate/Severe  0.214* Moderate/Severe   -610.902
PTSD (C2-Sx) x IC  (0.142) 
 
 PTSD (C2-Sx) x IC 
 
 (2338.684) 
 
Severe PTSD,   0.302      Severe PTSD,   2,660.516     
Mod Drug (C3-Sx) x IC  -0.223     
 
 Mod Drug (C3-Sx) x IC  (2621.770) 
   
Moderate/Severe PTSD,   0.584      Moderate/Severe PTSD,   -7458.706* 
Severe Drug (C4-Sx) x IC  (0.525) 
 
 Severe Drug (C4-Sx) x IC  (3,315.660) 
   
Severe PTSD, Moderate/Severe   0.135      Severe PTSD, Moderate/Severe  -2,448.352     
Alcohol, & Drugs (C5-Sx) x IC  (0.135) 
 
 Alcohol, & Drugs (C5-Sx) x IC  (2252.480) 
   
High alcohol (C6-Sx) x IC 
 
  0.350     
(0.279) 
 High alcohol (C6-Sx) x IC 
 
  -7495.390* 
(3,039.883)
  
High alcohol/Drug (C7-Sx) x IC 
 
  0.920     
 
 High alcohol/Drug (C7-Sx) x IC 
 
 -2,757.799     
 (0.749)
 
(2339.356)
 
 
 Age   0.990     
 
 Age   84.802     
     
   
   
   
   
   
   
     
      
   
    
   
    
   
   
    
   
    
     
   
       
    86 
(0.014)
 
 (57.869)
   
Hispanic   0.731     
 
 Hispanic  -52.687     
  (0.241)
 
 (986.362)
   
Black   0.494** 
 
 Black  -1,244.703     
  (0.130)
 
 (896.390)
   
Race-Other 
 
  0.839     
 
 Race-Other 
 
 -725.818     
 (0.271)
 
(889.605)
 
Less than   1.425     
 
 Less than   233.585     
high school
 
(0.348)
 
high school
 
(1110.627)
 
College   1.522     
 
 College  -153.501     
 (0.430)
 
 (1077.815)
   
Illness/disability  3.925**
 
  Illness/disability  3,490.997**
  (1.021)
 
  (806.783)
   
Current abuse   0.945     
 
 Current abuse   854.674     
 (0.227)
 
 (1,000.061)
   
Any insurance 
 
  1.632*  Any insurance 
 
  889.846     
 (0.376)
 
(917.833)
 
Court-ordered 
 
  0.470** 
 
 Court-ordered 
 
 -1,052.475     
 treatment (0.101) treatment (850.575)
 
 
 Perceived unmet need 
 
  1.279     
 
 Perceived unmet need 
 
 -4.212     
for care
 
    
   
    
(0.278)
 
for care
 
(837.606)
 
Constant 
 
  2.276** 
 
 Constant 
 
 -777.049     
 (0.673)  (2872.960)
n = 2,001     n = 1,893       
a Bootstrapped standard errors in parentheses; * significant at 5%; ** significant at 1%  
b Two-part model, logit for probability of any costs, OLS for level of costs for those with any costs. 
 
 
 
 Table 13.  Effect of IC on 12-month external medical costs by service clustersa
       
Logit  OR (SE)  OLS 
 
 
 Coefficient 
(SE)
     
(Reference group –       
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--  (Reference group – --
Low service use (C1-Serv)) 
 
-- Low service use (C1-Serv)) 
 
--
 
Moderate residential treatment   1.17      Moderate residential treatment  696.532 
days (C2-Serv)  (0.451) 
 
 days (C2-Serv)  (1550.838) 
    
High counseling    1.88      High counseling   941.641 
use (C3-Serv)  (-0.873) 
 
 use (C3-Serv)  (1580.451) 
    
High residential treatment   1.52      High residential treatment  -2310.563* 
days (C4-Serv)  (0.682) 
 
 days (C4-Serv)  (1,156.288) 
    
High psychotropic drug &   2.19      High psychotropic drug &  4,566.327* 
external medical costs (C5- 
 
 (1.038)  external medical costs (C5- 
  
 (1,864.637) 
 Serv)  Serv)
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IC treatment group 
 
  1.52      IC treatment group 
   
 -606.259 
 (0.476) (1275.327)
  
Moderate residential treatment   1.27      Moderate residential treatment  -145.512 
days (C2-Serv) x IC  (0.751) 
 
 days (C2-Serv) x IC  (2,001.218) 
    
High counseling    0.35      High counseling   396.097 
use (C3-Serv) x IC  (0.219) 
 
 use (C3-Serv) x IC  (2690.972) 
    
High residential treatment   1.62      High residential treatment  3,020.33 
days (C4-Serv) x IC  (1.249) 
 
 days (C4-Serv) x IC  (2252.384) 
    
High psychotropic drug &   0.97      High psychotropic drug &  177.256 
external medical costs   (0.763)  external medical costs   (2770.065) 
(C5-Serv) x IC    (C5-Serv) x IC   
  
Age   0.99      Age  50.809 
 (0.014)
 
 (54.718)
  
Hispanic   0.77      Hispanic  -321.695 
 (0.252)
 
 (951.801)
    
Black 0.514* Black -840.638
 (0.135)
 
 (881.703)
    
Race-Other   0.86     
(0.278)
 
 
Race-Other 
 
 -738.144 
(904.348)
  
Less than   1.45      Less than  306.002 
high school  (0.354)  high school  (-1075.342) 
 
      
    
  
    
     
  
     
  
     
     
   
    
     
     
  
College   1.58     
 
 College  -167.466 
 (0.445)
 
 (998.107)
    
Illness/disability  3.756**  Illness/disability  3,226.877**
 (0.969)
 
 (822.523)
    
Current abuse   0.96      Current abuse  854.986 
 (0.222)
 
 (860.854)
    
Any insurance   1.52      Any insurance 
 
 471.424 
 (0.349) (847.592)
  
Court-ordered  0.499**  Court-ordered
 
 -856.209
treatment (0.108) treatment  (850.836)
  
Perceived unmet need   1.26      Perceived unmet need  -300.158 
for care  (0.275)  for care  (841.19) 
  
Constant  2.298**  Constant       2,359.48 
   (0.664)     (2,789.083) 
n = 2,001     n = 1,893       
* significant at 5%; ** significant at 1%     
a Two-part model, logit for probability of any costs, OLS for level of costs for those with any costs.  
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 Table 14.  Effect of IC on 12-month total overall costs by clustera
       
Symptom clusters         
 
 
 Coefficient 
(SE)  Service clusters           
 
  
 Coefficient 
(SE)
    
(Reference group – Low alcohol,        
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-- (Reference group – --
Average drug, Low PTSD (C1-
Sx)) 
 
-- Low service use (C1-Serv)) 
 
--
 
Moderate/Severe  4,010.26  Moderate residential treatment  9,883.022** 
PTSD (C2-Sx)  (2901.393)  days (C2-Serv) 
 
 (2,982.724) 
  
Severe PTSD,  3,064.68  High counseling   9,703.038** 
Moderate Drug (C3-Sx)  (3016.312) 
 
 use (C3-Serv)  (3,221.983) 
   
Moderate/Severe PTSD,  11,326.813*  High residential treatment  11,450.631**
Severe Drug (C4-Sx)  (4,493.085) 
 
 days (C4-Serv)  (2,821.225) 
   
Severe PTSD, Moderate/Severe  2,382.73  High psychotropic drug &  9,704.808** 
Alcohol, & Drugs (C5-Sx)  (3726.817) 
 
 external medical costs (C5- 
 
 (2,998.378) 
  Serv)
 
High alcohol (C6-Sx) 
 
 10,851.316** 
 
    
(3,880.857)
 
High alcohol/Drug (C7-Sx) 
 
 7,914.338*     
(3,279.484)
 
IC treatment group 
 
 6,098.96  IC treatment group 
 
 123.684 
(3,242.723) (2,222.326)
 
 
 Moderate/Severe  
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 -8,564.05  Moderate residential treatment  6,100.81 
PTSD (C2-Sx) x IC 
 
 (4,372.599)  days (C2-Serv) x IC 
 
 (4,479.285) 
  
Severe PTSD,  -910.59  High counseling   -6,153.56 
Mod Drug (C3-Sx) x IC 
 
 (4,950.879) 
 
 use (C3-Serv) x IC 
 
 (4,746.269) 
  
Moderate/Severe PTSD,  -11,699.51  High residential treatment  -1,099.70 
Severe Drug (C4-Sx) x IC 
 
 (6,046.802) 
 
 days (C4-Serv) x IC 
 
 (4,515.741) 
  
Severe PTSD, Moderate/Severe  558.69  High psychotropic drug &  4,972.05 
Alcohol, & Drugs (C5-Sx) x IC 
 
 (5,558.82)  external medical costs   (4,341.103) 
  (C5-Serv) x IC   
High alcohol (C6-Sx) x IC 
 
 -12,882.548* 
 
    
(6,060.984)
 
High alcohol/Drug (C7-Sx) x IC  -3,497.16   
 (4,923.974)
 
 
 
Age 201.53 Age 196.67
 (104.216)
 
 (101.699)
   
Hispanic  -176.20 Hispanic -444.36
 (2,276.196)
 
 (2,271.499)
   
Black -1,642.83 Black
 
-1,177.27
(1,946.282)
 
(1,911.389)
  
Race-Other 
 
 -3,060.35
(2,219.2
Race-Other
 
-2,914.27
 87)
 
(2,208.296)
    
Less than  -4908.905*  Less than  -5175.212** 
high school  (1,940.334)  high school  (1,899.176) 
 
       
     
     
    
   
     
   
      
    
    
     
     
     
   
     
   
      
 
College  2,187.23 College
 
1,703.03
 (2144.33)
 
(2,113.754)
  
Illness/disability  4,129.675**  Illness/disability  3,445.167*
 (1,486.560)
 
 (1,476.400)
   
Current abuse  4,583.615**  Current abuse  4,989.368** 
(1,655.775)
 
 (1,574.152)
  
Any insurance  569.302  Any insurance 
  
 -315.55 
(1,670.463)  (1,643.228)
  
Court-ordered 
 
 5,314.695** Court-ordered
 
5,130.807**
treatment (1,652.961)
 
treatment
 
(1,656.702)
  
Perceived unmet need  -1,906.51 Perceived unmet -2,100.58
for care 
 
 (1,504.181) 
 
 need for care 
 
 (1,512.51) 
 
Constant 34,030.071** Constant 33,374.569**
   (4,964.667)       (4,860.346) 
n = 2,001; Robust standard errors in parentheses; * significant at 5%; ** significant at 1%   
a Ordinary Least Squares (OLS) models.   
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  Table 15. Summary of significant effects (95% confidence intervals) for IC v. usual care: latent class models a
   
Outpatient 
counseling 
Residential 
treatment 
External medical 
costs 
Total overall 
costs 
No unmet need for IC 
― ― 282.804          (15.600, 550.011) ― 
Unmet need for IC 
― 0.191          (0.095, 0.287) ― ― 
 a n = 2,001; All models controlled for individual- and program-level covariates.  Only coefficients  
 and confidence intervals that were statistically significant at the 95 percent level are reported here.   
  
 
 
  Table 16.  Effect of IC on 12-month outpatient counseling use by latent class 
     
‘No unmet need for care’  
 
Coefficient (SE)
 
 ‘Unmet need for care’  
  
 Coefficient (SE)
 
IC group  0.083  IC group 
 
 0.027 
     
       
   
      
    
    
    
       
   
       93
 (0.049) (0.11)
ASI-Alcohol   -0.106  ASI-Alcohol  
 
 0.014 
score  (0.088) score
 
 (0.166)
ASI-Drug   -0.009  ASI-Drug   -0.497 
score  (0.173)
 
 score
 
 (0.361)
 
PTSD score  0.005*  PTSD score 
 
 0.010* 
 (0.002)  (0.005)
Counseling visits -  0.008**  Counseling visits - 
 
 0.006** 
baseline  (0.001) baseline  (0.002)
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Psychotropic   0.000  Psychotropic   0.000 
med costs - baseline 
 
 (0.000)  med costs - baseline 
   
 (0.000) 
Residential treatment   0.002  Residential treatment   0.004* 
days - baseline   (0.001) 
 
 days - baseline  
  
 (0.002) 
 
External medical  0.000**  External medical  0.000 
costs - baseline  (0.000)  costs - baseline 
  
 (0.000) 
Age  0.006* Age
  
 0.006
 (0.003) (0.006)
Hispanic  -0.044 Hispanic
 
 -0.130
 (0.076)  (0.187)
Black  -0.240**
 
 Black
 
 -0.144
(0.067)  (0.143)
Other race  -0.121  Other race 
 
 0.052 
 (0.077)  (0.165)
Less than  -0.057  Less than  -0.183 
high school  (0.055)  high school 
 
 (0.123) 
College  -0.068 College
 
 -0.121
 (0.059)  (0.131)
Illness/disability  -0.038  Illness/disability
  
-0.011
 (0.047)  (0.105)
 
 Current abuse  0.051  Current abuse 
  
 0.011 
   
     
   
       
    
   
    
      
   
 (0.053)
 
 (0.113)
 
Any insurance  0.101  Any insurance 
  
 0.180 
 (0.059)  (0.123)
Court-ordered  0.182**  Court-ordered  0.156
treatment  (0.050)
 
  treatment
 
 (0.111)
 
Unmet need   0.025  Unmet need   -0.132 
for care  (0.048)  for care 
 
 (0.102) 
Constant  3.792**  Constant  3.267**
   (0.160)     (0.342) 
n = 2,001; Robust standard errors in parentheses; * significant at 5%; ** significant at 1% 
 
 
 Table 17.  Effect of IC on 12-month residential treatment use by latent class 
     
‘No unmet need for care’  
 
 Coefficient (SE)
 
 ‘Unmet need for care’  
  
 Coefficient (SE)
 
IC group  0.251  IC group  0.191**
   
   
   
   
     
   
      
 (0.136)
 
 (0.049)
 
ASI-Alcohol   0.568**
 
 ASI-Alcohol  
 
 0.021
score (0.194)
 
score (0.062)
 
ASI-Drug   1.367**  ASI-Drug   -0.017
score (0.476)
 
score (0.133)
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 PTSD score  -0.01  PTSD score  -0.002
   
   
    
   
  
  
     
   
   
     
   
   
     
   
   
   
   
    
       96
 (0.006)
 
 (0.002)
 
Counseling visits -  0.000  Counseling visits - 
 
 0.001
baseline (0.002)
 
baseline (0.001)
 
Psychotropic   0.000  Psychotropic   0.000
med costs - baseline 
 
 (0.000)
 
 med costs - baseline 
  
 (0.000)
 
Residential treatment   0.016**  Residential treatment   -0.001
days - baseline   (0.002)
 
 days - baseline  
 
 (0.001)
 
External medical  0.000  External medical  0.000
costs - baseline  (0.000)
 
 costs - baseline 
 
 (0.000)
 
Age 0.011 Age 0.003
 (0.008)
 
 (0.003)
 
Hispanic -0.244 Hispanic 0.088
 (0.209)
 
 (0.071)
 
Black 0.334* Black 0.050
 (0.150)
 
 (0.061)
 
Other race  0.141  Other race  -0.029
 (0.194)
 
 (0.071)
 
Less than  0.340*  Less than  -0.019
high school  (0.155)  high school  (0.053)
 
 
 
 College     
   
   
     
  
   
  
   
  
   
   
    
   
   
    
0.242 College -0.060
 (0.167)
 
 (0.059)
 
Illness/disability -0.131 Illness/disability
 
0.075
 (0.132)
 
 (0.044)
 
Current abuse  0.586**  Current abuse 
 
 0.062
 (0.160)
 
 (0.050)
 
Any insurance  -0.272*  Any insurance 
 
 0.036
 (0.132)
 
 (0.049)
 
Court-ordered 0.343**  Court-ordered 0.041
treatment (0.126)
 
 treatment (0.046)
 
Unmet need   -0.415**  Unmet need   0.001
for care  (0.125)
 
 for care  (0.043)
 
Constant 2.484**  Constant 4.771**
   (0.433)     (0.138)
n = 2,001; Robust standard errors in parentheses; * significant at 5%; ** significant at 1% 
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  Table 18.  Effect of IC on 12-month external medical costs by latent class 
     
‘No unmet need for care’  
 
Coefficient (SE)
 
 ‘Unmet need for care’  
  
  Coefficient (SE)
 
IC group  282.804*  IC group 
 
 -950.523 
    
     
   
    
    
    
     
    
      
   
     
  
   
    
    
     
 98
 (136.330)
 
 (2,692.830)
 
ASI-Alcohol   -287.105  ASI-Alcohol  
 
 -2,094.65 
score  (225.732)
 
 score
 
 (4655.798)
 
ASI-Drug   -294.54  ASI-Drug   -16,015.30 
score  (466.908)
 
 score
 
 (9339.813)
 
PTSD score 9.128  PTSD score
 
55.079
 (6.220)  (125.163)
 
Counseling visits -  -0.816  Counseling visits - 
 
 1.002 
baseline  (2.322) baseline
 
 (40.127)
 
Psychotropic   0.626**  Psychotropic   0.646 
med costs - baseline 
 
 (0.210)  med costs - baseline 
   
 (3.666) 
 
Residential Tx   7.784**  Residential Tx   -31.525 
days - baseline   (2.499) 
 
 days - baseline  
  
 (59.584) 
 
External medical  0.016  External medical  0.853** 
costs - baseline  (0.008)  costs - baseline 
  
 (0.178) 
 
Age  12.819 Age  187.436
 (8.141)  (170.45)
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Hispanic  146.925 Hispanic
 
 -2,153.70
 (229.122)
 
 (4332.493)
 
Black  -141.182 Black
 
 -4,062.25
 (172.43)
 
 (3862.32)
 
Other race  -44.84  Other race 
 
 -654.485 
 (201.13)
 
 (4191.456)
 
Less than  -9.77  Less than  3,101.79 
high school (161.224)
 
 high school
 
(3234.466)
 
College  -9.216 College
 
 -3,086.41
 (175.387)
 
 (3395.06)
 
Illness/disability  528.831** Illness/disability
  
3,891.20
 (136.724)
 
 (2796.396)
 
Current abuse  -56.341  Current abuse 
  
 3,212.91 
 (160.101)
 
 (2940.835)
 
Any insurance  460.568**  Any insurance 
  
 -945.443 
 (162.071)
 
 (3270.418)
 
Court-ordered  -170.053  Court-ordered  -2,262.78
treatment  (140.39)
 
  treatment
 
 (2984.891)
 
Unmet need   157.579  Unmet need   352.371 
for care  (126.024) 
 
 for care 
 
 (2632.025) 
 
 
 Constant  536.747  Constant      12,342.74 
   (435.632)     (8,690.310)  
n = 2,001; Robust standard errors in parentheses; * significant at 5%; ** significant at 1% 
 
  
 
 Table 19.  Effect of IC on 12-month total overall costs by latent class 
     
‘No unmet need for care’  
 
Coefficient (SE)
 
 ‘Unmet need for care’  
  
  Coefficient (SE)
 
IC group  395.060  IC group 
  
 -143.171 
     
     
   
    
    
    
    
      
   
    
  
   
              100
(946.155)
 
(4,707.456)
 
ASI-Alcohol   1,216.568  ASI-Alcohol  
 
 -7,775.690 
score  (1994.342)
 
 score
 
 (6,404.782)
 
ASI-Drug   10,575.547**  ASI-Drug   -7,288.786 
score  (3,731.625)
 
 score
 
 (14,107.796)
 
PTSD score  -37.148 
 
 PTSD score 
 
 152.310 
(44.72)  (209.599)
 
Counseling visits -  70.447**  Counseling visits - 
 
 56.154 
baseline  (16.210)
 
 baseline
 
 (75.851)
 
Psychotropic   5.878**  Psychotropic   5.182 
med costs - baseline 
 
 (1.507)  med costs - baseline 
   
 (6.32) 
 
Residential Tx  
ne  
 
 
191.702** 
(27.383) 
 
 
Residential Tx  
days - baseline  
 
 
-286.732** 
(76.740) days - baseli
    
 
 External medical  0.306**  External medical  0.013 
costs - baseline  (0.115)  costs - baseline 
  
 (0.175) 
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Age  53.018 Age  785.109**
 (57.881)
 
 (267.696)
 
Hispanic  -1,555.361 Hispanic
 
4,955.734
 (1,470.114)
 
 (7,123.03)
 
Black  -1,635.195 Black  -7,059.675
 (1,314.795)
 
 (5,793.035)
  
Other race  500.400  Other race 
 
 -13,701.184* 
 (1,448.528)
 
 (6,423.355)
 
Less than  -1,669.076  Less than  -11,037.931* 
high school  (1,121.231) 
 
 high school 
 
 (5,274.150) 
 
College  1,673.660 College
 
 -3,285.835
 (1,233.63)
 
 (5,669.546)
 
Illness/disability  1,286.264  Illness/disability
  
5,832.890
 (960.446)
 
 (4,410.628)
 
Current abuse  2,445.708*  Current abuse 
  
 7,174.152 
 (1,029.616)
 
 (4,849.835)
 
Any insurance  1,055.427  Any insurance 
  
 -2,006.683 
 (1,100.085)
 
 (4,829.773)
 
Court-ordered  3,770.909**  Court-ordered  8,636.085
treatment  (1,037.032)  treatment  (4,519.147)
 
        
    
   
Unmet need   -271.533  Unmet need   -4,353.237 
for care  (916.901) 
 
 for care 
 
 (4,252.669) 
 
Constant  23,850.482**  Constant  56,044.493**
   (3,123.576)      (13,323.088) 
n = 2,001; Robust standard errors in parentheses; * significant at 5%; ** significant at 1% 
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 Figures 
 
Figure 1.  Conceptual Model: Symptom severity as a moderator of treatment effects on services use and costs 
among women with co-occurring disorders and histories of abuse victimization 
 
 
Covariates: Program-level 
characteristics  
Covariates:  Individual-
level characteristics  
Services 
utilization: 
• Outpatient 
counseling 
• Residential 
treatment 
 
Services costs: 
• Medical costs 
• Total overall 
costs 
Treatment: 
 
Integrated counseling 
 
- OR - 
 
Usual care 
Baseline symptom 
severity clusters 
 
- OR - 
 
Baseline services use 
and costs clusters 
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